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Autophagy is a membrane trafficking pathway that delivers portions of 
the cytoplasm to lysosomes for degradation.  Degradation of damaged 
organelles and proteins allows autophagy to play key roles in 
maintaining cell and tissue homeostasis and reducing inflammation. 
Autophagy can also degrade intracellular pathogens and expose 
pathogen components to innate and adaptive immune systems. Recent 
work has identified LC3-associated phagocytosis (LAP) as a pathway 
related to autophagy that is activated during the phagocytosis of 
pathogens and may also facilitate delivery to lysosomes.  Autophagy 
protein Atg16L1 is required for both autophagy and LAP, and also for the 
suppression of secretion of the pro-inflammatory cytokine IL-1beta from 
macrophages. The N-terminal region of Atg16L1 contains a short atg5-
binding and coiled coil domain (CCD) that binds WIPI2b and is required 
for autophagy.  The large C-terminal domain is made from seven 
tryptophan-aspartic acid (WD) repeats folded into a -propeller thought 
to provide a platform for protein interactions important for autophagy.  
This study has used mice lacking the WD domain of Atg16L1 to 
investigate the role played by these domains in determining the 
inflammatory status of macrophages. Mice carrying a stop codon at the 
end of the CCD were unable to express the WD domain.  The 
inflammatory status of macrophages isolated from these mice was 
compared with macrophages carrying an additional deletion that 
removed a glutamate residue at position 230 in the CCD required for 
WIPI2b binding and autophagy. Bone marrow-derived macrophages 
from mice lacking both the WD domain and glutamate 230 were unable 
to induce autophagy. They were also unable to suppress IL-1beta 
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secretion in response to LPS or differentiate into anti-inflammatory M2 
macrophages. Mice that lacked the WD domain of Atg16L1, but retained 
glutamate 230 could activate autophagy, suppress inflammation and 
differentiate into anti-inflammatory macrophages. These results 
suggested that the inflammatory status of macrophages is maintained 
independently of the WD domain, and relies on the short N-terminal 
coiled coil domain of Atg16L1, which is able to activate autophagy.  
Parallel studies following the uptake of polystyrene beads by 
macrophages showed that the WD domain of Atg16L1 was required for 
LAP.   LAP is therefore activated during phagocytosis, but since the 
inflammatory status of macrophages is independent of the WD domain, 
LAP does not appear to play a role in suppressing inflammatory 
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1.1 Autophagy  
Autophagy is a general term for the transfer of material from the 
cytoplasm to lysosomes for degradation.  There are several different 
pathways including chaperone-mediated autophagy and 
microautophagy.  The pathway studied in this thesis is called macro-
autophagy, but as is conventional for studies of macro-autophagy, the 
pathway will be referred to as autophagy from now on. During 
autophagy, new membranes called autophagosomes are generated in 
cells and these engulf portions of the cytoplasm and fuse with 
lysosomes and their content is degraded.  Autophagy plays an important 
role in maintaining tissue homeostasis by removing damaged organelles, 
protein aggregates and intracellular pathogens.  Cargoes for autophagy 
are engulfed by a flattened membranous sac-like structure, called a 
phagophore, that elongates and seals to become the double-
membraned autophagosome (Levine et al, 2011; Shibutani et al, 2015; 
Zavodsky et al, 2013). The mature autophagosomes use the microtubule 
motor protein dynein to move along microtubule tracts to perinuclear 
sites where lysosomes are clustered. The outer membrane of the 
autophagosomes fuses with the lysosomes to form autolysosomes 
which degrade the cargoes together with the inner autophagosome 
membrane (Zavodsky et al, 2013). The degradation products, such as 
amino acids, are recycled and used for metabolic processes and 
maintaining cellular homeostasis. Autophagy of damaged organelles, 
protein aggregates as well as pathogens involves the tagging of the 
potential cargo with poly-ubiquitin which binds an adaptor protein 
called p62 which in turn binds LC3 in the autophagosome membrane 
(Figure 1.1).  Autophagy directed against pathogens, is termed 
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xenophagy, and plays a crucial role in suppressing excessive 
inflammatory responses. Capture of pathogens inside autophagosomes 
and subsequent killing in lysosomes can prevent dispersal of microbes to 
other cells and supress the inflammatory stimulus generated during 























Figure 1.1 Different subsets of autophagy pathways. Three different 
autophagy subsets have been described depending on the cargo that is 
degraded. Damaged organelles, protein aggregates as well as pathogens 
get tagged with poly-ubiquitin (Ub) which binds an adaptor protein, p62, 
which in turn binds LC3 in the autophagosome membrane. Xenophagy is 
involved in the clearance of pathogens and has an essential role in 
suppressing inflammatory responses. Mitophagy leads to degradation of 
damaged mitochondria while aggrephagy results in degradation of 










1.1.i Mechanism of autophagosome formation    
Autophagosomes were reported in electron microscopy studies in the 
1950s, however the molecular mechanism of autophagy remained 
unknown until the discovery of yeast autophagy-related genes in the 
1990s. More than 40 autophagy-related (Atg) proteins have been 
reported so far, of which 15 core proteins in yeasts are conserved in 
mammals, indicating that autophagy is an evolutionarily conserved 
process (Shibutani et al, 2015). In mammals, the initiation of 
phagophore formation is regulated by the mTOR kinase that senses the 
levels of amino acids in cells (Zavodsky et al, 2013) (Figure 1.2i).  Under 
nutrient-rich conditions mTOR is active and promotes protein synthesis.  
During this process mTOR phosphorylates and inactivates the ULK1 
kinase and Atg13.  When amino acid levels fall, mTOR is inactivated and 
the inhibition of ULK1 and Atg13 is reversed (Kim et al, 2011).   The next 
stage involves a complex containing the class III phosphatidylinositol 3-
kinase (PI3K) Vps34, Beclin 1, Vps15 complex, and Atg2-WIPI2b complex. 
ULK1 activates the complex by phosphorylating Beclin, the main 
regulatory subunit of the Vps34 complex.  The main function of the 
Vps34 complex is to phosphorylate lipids in cellular membranes, most 
commonly the endoplasmic reticulum, to generate binding sites for 
phospholipid-binding proteins such as WIPI2b which recruit the proteins 
required autophagosome expansion (Dooley et al, 2014).    
The expansion, elongation and closure of the phagophore depends on 
two ubiquitin-like systems: the Atg12-Atg5 conjugation system which 
functions as a dimeric complex together with Atg16L1, and the 
microtubule-associated protein 1 light chain 3 (LC3) conjugation system 
(Levine et al, 2011; Zavodsky et al, 2013) (Figure 1.2ii). The ubiquitin-like 
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protein Atg12 is covalently linked to Atg5 by an E1-like enzyme, Atg7, 
and an E2-like enzyme, Atg10 (Shibutani et al, 2015). The N-terminal 
domain of Atg16L1 binds WIPI2b and at the same time is non-covalently 
bound to the Atg12-Atg5 complex, inducing its multimerization and the 
formation of 2:2:2 complex (Mizushima et al, 2003).   
Atg12-Atg5-Atg16L1 is localised on the outer surface of the phagophore 
and dissociates after the mature autophagosome has been formed 
(Zavodsky et al, 2013). The Atg16L1 complex functions as an E3-like 
enzyme for the LC3 conjugation system. LC3 is a ubiquitin-like protein 
which, after synthesis, is processed by the Atg4 protease. The processing 
involves the removal of the C-terminal 22 residues of the precursor 
protein to generate the LC3-I form. The C-terminus of LC3-I is 
conjugated to phosphatidylethanolamine (PE) by a series of reactions 
involving Atg7, Atg3, as well as the Atg12-Atg5-Atg16L1 complex, thus 
resulting in the production of the lipidated form of LC3, LC3-II (Fujita et 
al, 2008). Prior to the fusion of the autophagosome with a lysosome, the 
LC3-II linked to the outer autophagosomal membrane dissociates by the 
deconjugation of PE from LC3, a process catalysed by the Atg4 protease. 
The LC3-II which is located on the inner autophagosomal membrane is 
retained but eventually degraded by the lysosomal hydrolases 
(Lai&Devenish, 2012) (Figure 1.2iii). GFP-LC3 is a widely used as a 
fluorescent marker for the detection of phagophores and 
autophagosomes by microscopy. Moreover, LC3-I and LC3-II can easily 
be detected by immunoblot (Figure 1.2iv) and the levels of LC3-II relative 





1.2 Autophagy and inflammation:  a link between Atg16L1 and Crohn’s  
disease  
The first evidence for a link between autophagy and inflammation was 
made by Saitoh and colleagues (2008) who showed that peritoneal and 
bone marrow-derived macrophages cultured from mice lacking Atg16L1, 
generated very high levels of IL-1beta in response to LPS. This suggested 
that autophagy may supress secretion of IL-1beta in response to TLR4 
signalling. During the same period genome-wide association studies 
(GWAS) identified a T300A risk allele for Crohn’s disease (CD) in the 
linker region of Atg16L1 (Hampe et al, 2007) suggesting that a 
malfunctioning Atg16L1 may in some way inhibit autophagy and 
predispose to inflammatory disease. The connection was further 
supported by work from Murthy et al (2014) who showed that the 
T300A mutation generated a caspase-3 cleavage site that could lead to 
degradation of Atg16L1, and by implication loss of autophagy, during 
environmental challenges that would activate caspase-3. The study went 
on to show that pathogen infection accelerated Atg16L1 cleavage which 
in turn impaired autophagy and resulted in increased cytokine 
production. Similarly, Lassen et al (2014), as well as Gao et al (2017), 
have demonstrated both in vitro and in vivo that Atg16L1 T300A mice 
exhibit autophagy defects and increased IL-1beta generation which is 











Figure 1.2 Regulation of autophagy and autophagosome formation in 
mammals. Autophagy is a complex catabolic process that involves the 
following key steps: i) mTOR kinase which senses the amino acid levels in 
the cell and promotes protein synthesis under nutrient-rich conditions. 
Under starvation, mTOR is inactivated which activates ULK1 and Atg13. 
ULK1 activates Beclin 1, the main regulatory subunit of the Vps34 complex. 
Vps34 is required for cellular membrane lipid phosphorylation, thus 
generating binding sites for WIPI2b which recruits the proteins involved in 
autophagosome expansion; ii) Atg12-Atg5-Atg16L1 conjugation system 
which is involved in the expansion, elongation and closure of the 
phagophore. The complex functions as an E3-like enzyme for the LC3 
conjugation system. LC3-I get lapidated by a series of reactions, thus 
resulting in the generation of LC3II which is linked to the autophagosomal 
membrane; iii) The autophagosome fuses with a lysosome which leads to 
the degradation of the engulfed cargo by the lysosomal hydrolases; iv) LC3 
can easily be detected by immunoblot or immunofluorescence. Moreover, 
the levels of LC3-II relative to LC3-I can be used for determining autophagy 
activation. [Figure provided by Tom Wileman]. 
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Parallel work from Cadwell et al (2008), using hypomorphic mice 
expressing low levels of Atg16L1 (Atg16L1HM) showed that the mice 
developed gut inflammation and Paneth cell defects similar to that seen 
in CD.  The inflammation was not seen in pathogen free mice but was 
induced by persistent strains of norovirus.  The study suggested that 
inflammation results from dysregulated immune responses to gut 
microbes. The following sections summarise the evidence that loss of 
autophagy may be pro-inflammatory.    
1.2.i Loss of autophagy from myeloid cells is pro-inflammatory    
Myeloid cells are widely distributed throughout the body and are key 
regulators of both innate and adaptive immunity (Murray&Wynn, 2011; 
Ohashi et al, 2015). They play a vital part in the host defence system 
because they constantly survey their surroundings for invading 
pathogens and have the capacity to contain pathogens in the early 
phase of infection (Murray&Wynn, 2011; Wang et al, 2013). 
Inflammation resulting from tissue damage or invasive pathogens 
stimulates macrophages to secrete proinflammatory cytokines and 
chemokines, as well as other inflammatory mediators, thus activating 
lymphocytes and other immune cells (Ohashi et al, 2015; 
Murray&Wynn, 2011). On the other hand, macrophages can play 
antiinflammatory roles in wound healing and tissue repair because of 
their role in inflammation resolution and the ability to produce anti-
inflammatory cytokines and to ingest pathogens due to their phagocytic 
activity (Ohashi et al, 2015). Inflammatory homeostasis therefore 




A complete knock-out of autophagy in mice through inactivation of 
genes essential for autophagy such as Atg5, Atg4, Atg7, Atg12 and Atg16 
results in postnatal death (Komatsu et al, 2005; Sou et al, 2008; Saitoh et 
al, 2008; Malhotra et al, 2015; Yoshii et al, 2016).  This has meant that 
most studies on the role played by autophagy genes in vivo rely on 
tissue-specific knock-out.  The lysozyme-M-cre system (LysMcre) has 
been used to knock out autophagy genes from myeloid cells 
(macrophage, neutrophils, dendritic cells, eosinophils).  Mice expressing 
cre recombinase from a lysozyme promoter are crossed with mice 
carrying autophagy genes flanked by floxp sites.  The resulting offspring 
survive but lack autophagy in myeloid cells.    
Studies using mice lacking Atg14, Fip200, Atg5 or Atg7 in myeloid cells 
show increased lung inflammation and increased resistance to influenza 
infection (Lu et al, 2016).  The mice are resistant to infection because 
the lung is proinflammatory at the time of infection and innate and 
acquired immune responses are accelerated.  Investigators (Park et al, 
2016) have also studied infection of these mice with murine gamma 
herpesvirus 68.  The autophagy deficient mice show raised systemic 
inflammation following infection and sustained production of IFN-
gamma by T-cells.  Taken together, the results suggest that the 
autophagy genes in macrophages supress virus-induced inflammation in 
vivo.    
Tissue macrophages originate from self-renewing multipotent 
haematopoietic stem cells which multiply in the bone marrow and give 
rise to blood monocytes. These cells do not divide but enter the blood 
stream and colonise various tissues where they differentiate into mature 
tissue-specific macrophages which have distinct morphological and 
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functional features. The differentiation is triggered by the cytokine 
environment (Gordon&Taylor, 2005; Mosser&Edwards, 2008; 
Lawrence&Natoli, 2011; Fejer et al, 2015). It has been shown that 
certain macrophage subsets do not originate from a single lineage. For 
example, brain macrophages (microglia) and epidermal macrophages 
(Langerhans cells) have dual origin (embryonic and adult bone marrow). 
Interestingly, Langerhans cells and lung macrophages (alveolar) come 
from the foetal liver. Tissue-specific macrophages also include 
osteoblasts (bone), histiocytes (intestinal connective tissue), marginal 
zone macrophages (spleen), subcapsular sinus macrophages of lymph 
nodes (Murray&Wynn, 2011).   
1.2.ii Effect of autophagy on M1 and M2 macrophages   
The tissue environment provides a source of signals which shape 
macrophage activation and the subsequent gene and protein expression 
(Roszer, 2015). Two major macrophage subtypes with distinct functions 
have been described termed classically activated M1 and alternatively 
activated M2 macrophages (Murray&Wynn, 2011; Ohashi et al, 2015). 
Macrophages exposed to pathogen components and IFN-gamma 
become M1 macrophages which produce proinflammatory cytokines 
and chemokines and play a role in inflammation, tissue damage and 
killing of the phagocytosed microbes (Figure 1.3). They are characterized 
by the expression of markers, such as IL-6, which is a pleiotropic, 
hormone-like molecule whose deficiency is associated with impaired 
innate and adaptive immunity to viral, parasitic and bacterial infection; 
and Ptgs2 (prostaglandin-endoperoxide synthase 2), an enzyme which 
converts arachidonic acid to prostaglandins which are dramatically 
increased during inflammation (Ohashi et al, 2015; Hunter&Jones, 2015; 
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Morita, 2002). Conversely, M2 macrophages are a result of the activity 
of IL-4 and IL-13 which are produced by Th-2 cells, basophils and mast 
cells (Figure 1.3). M2 polarized macrophages are characterized by the 
production of anti-inflammatory cytokines and by the expression of 
certain markers, such as arginase-1 and chinase-3 which are involved in 
tissue remodelling and healing (Ohashi et al, 2015; Varin&Gordon, 
2009). Arginase-1 is an enzyme which uses L-arginine to produce L-
ornithine and urea. Its increased activity is associated with enhanced L-
arginine metabolism which has been demonstrated to play a role in T-
cell proliferation (Roszer, 2015; Gabrilovich&Nagaraj, 2009). Chinase-3 is 
a lectin which binds to heparin and heparin sulfate during pathogen 
infection. It displays chemotactic activity for T lymphocytes and is 
involved in inflammatory responses (Morita, 2002).    
Autophagy appears to play a role in regulating M1/M2 polarisation in 
vivo.  When Atg5 LysMcre mice, which lack autophagy in myeloid cells, are 
raised on a high fat diet containing low levels of LPS, they develop 
systemic inflammation and liver damage.  Bone marrow-derived 
macrophages and Kupffer cells isolated form the mice show increased 
M1 phenotype compared to litter mate controls.  The results suggest 
that in control mice Atg5 favours differentiation of macrophages into an 
anti-inflammatory M2 phenotype (Liu et al, 2015).  The mechanism is 
unknown but may be related to the ability of autophagy to provide 
metabolites.  M1 and M2 polarized macrophages differ in their 
metabolic profile. Classically activated M1 macrophages rely on 
glycolysis which is a process of quick energy supply needed during 
microbicidal activity. In contrast, alternatively activated M2 
macrophages obtain much of their energy from fatty acid oxidation 
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which provides sustained energy for tissue repair and remodelling 


















Figure 1.3 M1 vs M2 macrophages. LPS and IFN-gamma induce 
proinflammatory M1 macrophage polarization, whereas exposure to IL-4 
and IL13 results in anti-inflammatory M2 phenotype. Upon ligand binding, 
latent cytoplasmic STAT transcription factors get activated which results in 
their homo- or heterodimerization and translocation to the nucleus, where 
they bind to DNA and regulate gene expression. The M1 macrophages are 
involved in inflammation, tissue damage and killing of invasive pathogens 
and are therefore characterized by the production of IL-6 and Ptgs2, 
whereas the M2 macrophages have anti-inflammatory properties and are 
involved in tissue remodeling and healing. Their marker expression profile 
is characterized by arginase-1 and chinase-3.  
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1.2.iii Autophagy and Toll-like receptors  
In addition to being activated by starvation, autophagy can be activated 
by Toll-like receptor (TLR) signalling during infection.  TLRs are 
transmembrane glycoproteins composed of an extracellular portion, 
containing leucine-rich repeat motifs (LRR) which are involved in the 
recognition of pathogenassociated molecular patterns (PAMPs); a 
transmembrane domain and a cytoplasmic domain which induces signal-
transduction pathways (Akira et al, 2006; Vural&Kehrl, 2014) (Figure 
1.4). TLRs are expressed predominantly on immune cells, such as 
macrophages, dendritic cells, B cells, T cells but can also be expressed on 
non-immune cells, such as fibroblasts and epithelial cells (Akira et al, 
2006). Furthermore, they are positioned either on the cell surface or in 
intracellular compartments, such as endosomes, and lysosomes. The 
TLRs which are expressed in intracellular vesicles recognise ligands, 
mainly nucleic acids, which require internalization before signalling is 
possible. TLR1, TLR2, TLR4, TLR5, TLR6, and TLR10 are localised on the 
plasma membrane and recognise proteins, lipids and lipoproteins, 
whereas TLR3, TLR7, TLR8, and TLR9 are positioned in intracellular 
compartments and recognise pathogen nucleic acids. Interestingly, 
some TLRs bind to structurally unrelated ligands. One example is TLR4 
which recognises viral proteins, fibronectin, heat-shock proteins as well 
as lipopolysaccharide (LPS), a signature component found on the 
membrane of Gram-negative bacteria (Akira et al, 2006; Vural&Kehrl, 







Figure 1.4 Mechanism of TLR4 stimulation and NF-kB activation. The 
extracellular domain of TLR4 recognizes LPS and transduces the signal 
with the help of the intracellular domain. IkB gets phosphorylated and 
ubiquitinated which results in its proteolytic degradation. NF-kB in turn 








1.2.iv TLR4 and lipopolysaccharide    
TLR expression is not a static but a dynamic process which corresponds 
to the pathogen, a variety of cytokines, as well as environmental 
stresses (Akira et al, 2006). The binding of PAMPs to TLRs initiates the 
innate immune response which then induces the adaptive immunity. 
Stimulation of different TLRs leads to diverse biological responses as 
various adaptor proteins are recruited to them which results in 
induction of different transduction pathways (Vural&Kehrl, 2014). One 
of the most extensively studied Toll-like receptors is TLR4. In 1999 MD2, 
myeloid differentiation factor 2, was shown to bind to LPS and confer its 
responsiveness to TLR4. The 18-25 kDa MD2 protein has been 
demonstrated to be the LPS co-receptor which is essential for the 
normal function of TLR4 and the subsequent activation of NF-kB (O’Neill 
et al, 2013) (Figure 1.4). NF-kB is a transcription factor involved in 
inflammation, immune response regulation, differentiation, and 
apoptosis. In resting cells, NF-kB is in the cytoplasm and is bound to the 
IkB inhibitor. Upon stimulation, IkB gets phosphorylated by the IkB 
kinase (IKK) complex which results in polyubiquitination and degradation 
of IkB. NF-kB translocates to the nucleus and induces the expression of 
various genes involved in inflammation and apoptosis (Sollberger et al, 
2014).  
After TLR stimulation, MyD88 mediates the recruitment of IRAK-4 
followed by IRAK-1/2 (Figure 1.5). This complex interacts with TRAF6 
which induces Lys63linked polyubiquitination of target proteins, 
including IRAK-1 (Lys63-linked polyubiquitin chains play a role in the 




Figure 1.5 The TLR4 signalling pathway and role of A20 in NF-kB 
inhibition. The TLR4 stimulation involves the recruitment of various 
protein complexes (shown in coloured boxes) which induces Lys63-
linked polyubiquitination and generation of free Lys63-linked 
polyubiquitin chains which in turn leads to the activation of the IKK 
complex. The IKK complex phosphorylates the IkB complex resulting in 
its degradation and subsequent activation of NF-kB. A20 cleaves Lys63-
linked chains which leads to negative regulation of NF-kB and 




linked polyubiquitin chains which are involved in the induction of a 
series of proteins, leading to the activation of the IKK complex and the 
subsequent NF-kB signalling. Excessive induction of the TLR pathway is 
linked to the development of inflammatory disorders. Therefore, cells 
have regulatory mechanisms to ‘’fine-tune’’ TLR signalling. The 
ubiquitin-modifying enzyme A20 cleaves Lys63-linked chains and 
promotes the generation of Lys48-linked chains (Lys48-linked chains 
target proteins for degradation), resulting in negative regulation of NF-
kB and suppression of the TLR signalling (Inomata et al, 2012; Duong et 
al, 2015). However, a negative regulatory system, if sustained, inhibits 
the response of the host to invasive pathogens. Therefore, immune 
suppression by A20 must be tightly regulated under stress conditions. 
Interestingly, autophagy has been shown to sequester A20 for 
degradation in tissue macrophages, thus inducing NF-kB activation. This 
allows macrophages to release chemokines and recruit neutrophils. It 
has been demonstrated that mice lacking autophagy in myeloid cells are 
prone to fungal infection due to impaired neutrophil recruitment 
(Kanayama et al, 2015).  
1.2.v The inflammasome  
The inflammasome is composed of a pathogen recognition receptor 
(PRR) of the NOD-like receptor (NLR) family such as NLRP1, NLR family 
pyrin domain containing 3 (NLRP3), NLR family CARD domain containing 
protein 4 (NLRC4), or the DNA-sensing absent in melanoma 2 (AIM2) 
(Denes et al, 2012). The cytosolic NLR family of PRRs function to sense 
and respond to stresses in the intracellular compartments. NLR 
members are classified based on their domain structure. The N-terminus 
can include a pyrin domain (PYD), a caspase-recruitment domain (CARD), 
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or a baculovirus inhibitory repeat (BIR) domain. The central nucleotide-
binding oligomerization domain (NACHT) is common for all NLR 
members, followed by a C-terminal leucine-rich domain (LRR). The LRR 
domain is involved in the PAMP/DAMP sensing, whereas the N-terminal 
domain is essential for the recruitment of other inflammasome proteins, 
such as ASC and procaspase-1 (Denes et al, 2012). NLRP3 is the most 
characterised inflammasome complex which recognises a wide range of 
structurally diverse stimuli, such as pathogens, pore-forming toxins, ATP, 
monosodium urate crystals, cholesterol crystals, LPS, MDP, and bacterial 
RNA. In contrast, NLRP1 is activated by anthrax lethal toxin; NLRC4 is 
induced by several Gram-negative bacteria; AIM2 is stimulated by 
cytosolic doublestranded DNA (Franchi et al, 2009; Shi et al, 2012; 
Deretic, 2012).   
Upon detecting cellular threat, NLRP3 oligomerises and exposes an N-
terminal PYD domain for interaction with the PYD domain of the adaptor 
apoptosisassociated speck-like protein ASC (which relocates upon 
inflammation from the nucleus to the cytosol), which in turn recruits 
procaspase-1, resulting in its activation and cleavage of the precursor 
proIL-1beta into its active form (Qiao et al, 2012; Gurung&Kanneganti, 
2015). Caspase-1 was described in 1989 as an inflammatory protease 
which induces the pro-inflammatory cytokines IL1beta and IL-18 
(Sollberger et al, 2014). Pathogen and endogenous signals stimulate the 
procaspase-1 zymogen which results in auto-cleavage and the 
production of the active heterodimer consisting of two 10- and 20-kDa 
subunits, which can activate proIL-1beta and proIL-18 (Franchi et al, 
2009) (Figure 1.6).   
39  
  
The NLRP3 inflammasome is induced through different receptor 
signalling pathways, such as TLRs. The stimulation of the Toll-like 
receptors and the subsequent activation of NF-kB is crucial for the 
transcriptional upregulation of both NLRP3 and proIL-1beta because 
their basal levels are inadequate for the inflammasome function. 
Moreover, NLRP3 is maintained in the cytosol in a ubiquitinated state 
which, upon stimulation, is capable of oligomerization after 
deubiquitination. In contrast, ASC and procaspase-1 are not adequate 
concentrations in the steady state (Sutterwala et al, 2014). The fact that 
proIL1beta levels are usually low requires its transcriptional 
upregulation which, as already described, is mediated by TLR stimulation 
and NF-kB activation. However, for the NLRP3 to function efficiently, a 
microbial ligand alone is not sufficient. An additional signal is required to 
activate the inflammasome, which can be extracellular ATP, bacterial 
toxins, or certain crystals (Franchi et al, 2009). An exception is the 
induction of the inflammasome by the TLR4 ligand LPS under conditions 













Figure 1.6 NLRP3 assembly and IL-1beta production and secretion. 
Upon stimulation, NLRP3 interacts with the adaptor apoptosis-
associated speck-like protein ASC which in turn recruits caspase-1, 
resulting in its activation and cleavage of the precursor proIL-1beta (blue 
+ purple) into its active IL-1beta form (purple). The cleavage site is 
marked with a red asterisk. NF-kB is also shown as it modulates proIL-








1.2.vi Caspase-8    
Caspase-8 has long been recognised for its role in apoptosis. However, 
new evidence has shown the essential function of this protease in the 
regulation of inflammation. It has been demonstrated that caspase-8 is 
involved in NFkB activation and for direct or indirect cleavage of proIL-
1beta, with or without the help of caspase-1. Different studies have 
demonstrated the role of caspase-8 in the release of pro-inflammatory 
cytokines. Murine B cells lacking caspase-8 expression exhibit 
compromised phosphorylation and nuclear translocation of the p65 
subunit of NF-kB, resulting in decreased IL-6, TNF and IFN-beta levels 
after LPS treatment. Another function of caspase-8 is to activate 
caspase-1 which can then cleave proIL-1beta and proIL-18. In vitro 
studies have shown that caspase-8 cleaves caspase-1, leading to the full 
activation of caspase-1 and the subsequent induction of proIL-1beta and 
proIL-18 in response to LPS and ATP. It has also been reported that both 
caspases act synergistically to activate proIL-1beta but the molecular 
mechanisms underlying this function remain to be described 
(Man&Kanneganti, 2016). Other studies have demonstrated the binding 
of caspase-8 to ASC, suggesting that the protease is an active member of 
the inflammasome, however, the exact role of caspase-8 in the 
inflammasome induction remains unknown (Guo et al, 2015).  
1.2.vii IL-1beta  
IL-1beta is a pleiotropic, pro-inflammatory cytokine which is involved in 
the initiation of the innate immune response (Harris, 2013; O’Neill et al, 
2013; Hailey et al, 2009). Although it is secreted by various cell types, 
the majority of studies focus on its production by immune cells, such as 
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monocytes and macrophages (Denes et al, 2012). IL-1beta was reported 
to play a crucial role in T-cell activation and the activation of the acute 
phase response (O’Neill et al, 2013). Systemic consequences of IL-1beta 
production include fever, hypotension and vasodilatation, whereas 
locally, the cytokine induces the expression of adhesion molecules on 
mesenchymal and endothelial cells which facilitates the recruitment of 
immune cells. The recruited lymphocytes and myeloid cells are then 
activated which enhances the inflammatory response (Gaidt&Hornung, 
2017).   
Proteins such as IL-1beta, IL-18 or fibroblast growth factor (FGF)-2 serve 
extracellular functions but they lack a signal peptide which would allow 
their endoplasmic reticulum (ER)/Golgi-dependent secretion. However, 
these proteins get secreted through mechanisms which are poorly 
understood, termed unconventional protein secretion (Sollberger et al, 
2014).  
Although crucial in the immune response, over-generation of IL-1beta 
can result in both acute (sepsis) and chronic (diabetes, rheumatoid 
arthritis, and artherosclerosis) disease. Therefore, its expression, 
production and secretion are tightly regulated. IL-1beta is synthesized as 
a biologically inactive 269residue precursor (31 kDa) protein, termed 
proIL-1beta. Caspase-1 and caspase-8 have been shown to cleave proIL-
1beta to generate the 153-residue active form from the C-terminal 
domain. Two cleavage sites in proIL-1beta have been reported: 
Asp272Gly28 and Asp1162Ala117 (Figure 1.7). The cleavage starts at 
Asp272Gly28 followed by Asp1162Ala117, resulting in the production of 
the 17 kDa active form of IL-1beta which is then exported by a non-
conventional secretion mechanism. Interestingly, proIL-1beta is 
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protease sensitive along the entire amino acid sequence, including the 
section which forms the mature cytokine. IL-1beta, however, is protease 
resistant under the same conditions. Moreover, the biologically inactive 
N-terminus inhibits the folding of the C-terminal domain but maintains 
the protein in a conformation which is primed to fold quickly after 
cleavage (Hailey et al, 2009).  
1.3 Structure and function of Atg16L1    
As already discussed, the potential link between Atg16L1 and 
inflammation was made when a T300A mutation in Atg16L1 was found 
to be a risk allele Crohn’s disease.  The protein is encoded by the 
Atg16L1 gene which is located on chromosome 1 or 2 in mice or 
humans, respectively, and contains 607 amino acids.  Atg16L1 expressed 
by mammals contains an N-terminal domain that binds Atg5 followed by 
a coiled coil domain (CCD) attached via a linker region to a larger C-
terminal WD (tryptophan-aspartate) domain containing 7 WD repeats 
(Mizushima et al, 2003) (Figure 1.8).   
The Atg5 binding domain binds the Atg5-Atg12 conjugate via Atg5, and 
selfassociations between CCD of Atg16L1 generate a large 800kDa 
complex that is required for conjugation of phosphatidylethanolamine 
(PE) to LC3 (Fujita et al, 2008).  The CCD also provides a binding site for 
the PtdIns(3)P effector protein WIPI2b ensuring localised incorporation 
of lipidated LC3 into the autophagosome membrane (Dooley et al, 
2014).  Binding of Atg16L1 to WIPI2b requires glutamate residues E226 
and E230 in the Atg16L1 CCD which bind arginines R108 and R125 
exposed on the surface of WIPI2b.  Deletion of either E226 or E230 in 





Figure 1.7 Schematic representation of proIL-1beta and caspase-1 
cleavage sites. White boxes indicate the inactive part of the protein, 
whereas the blue box represents that part of proIL-1beta which, after 
caspase cleavage (cleavage sites are highlighted in red), folds to form 




              
Figure 1.8 Structure and function of mammalian Atg16L1. Atg16L1 
consists of an N-terminal Atg5-binding (Atg5b) domain followed by a 
coiled coil domain (CCD) which is attached by the C-terminal WD domain 
via a linker region containing the Crohn’s disease risk allele T300A 
(indicated with an asterisk). Glutamate residues E226 and E230 in the 
CCD are required for the binding of Atg16L1 to WIPI2b, thus ensuring 
the incorporation of LC3-II into the autophagosome membrane. The 
interaction between the CCD with both Atg5-Atg12 and WIPI2b is 
required for LC3-I lipidation and autophagosome formation. [Figure 







R108 and R125 is unable to reconstitute LC3 recruitment to 
autophagosomes in WIPI2b depleted cells (Dooley et al, 2014) (Figure 
1.8).  The direct interaction between the CCD of Atg16L1 with both the 
Atg5-12 conjugate and the PtdIns(3)P effector protein WIPI2b is 
therefore required for LC3 conjugation to PE and autophagosome 
formation.    
The CCD of Atg16L1 provides binding sites for Atg5 and WIPI2b, but the 
precise role played by the large C-terminal WD domain of Atg16L1 is 
unknown. The seven WD repeat domains generate a circular -propeller 
(Bajagic et al, 2017) that is thought to provide a rigid scaffold to co-
ordinate assembly of multiple protein complexes, and it is generally 
believed that the 800kD Atg5-12:16L1 complex provides a platform for 
protein:protein interactions important for autophagy. Several proteins 
that bind the WD domain of Atg16L1 are linked to pathogen clearance 
suggesting that the WD domain has evolved in higher eukaryotes to link 
autophagy to pathogen clearance and inflammation. These include 
pattern recognition receptors, such as TLR2 and NOD-like receptor 
NOD2, and TRIM20 which inhibits inflammasome-mediated activation of 
IL1beta (Boada-Romero et al, 2013; Kimura et al, 2015; Bajagic et al, 
2017).  The WD domain of Atg16L1 also binds the cytoplasmic tail of 
transmembrane protein TMEM59 which directs LC3 to endosomes 
containing Staphylococci (Boada-Romero et al, 2016).    
The work of Murthy et al (2014) place T300A CD risk allele in the linker 
region of Atg16L1.  This increases sensitivity of Atg16L1 to caspase-3-
mediated processing and is generally believed to compromise 
autophagy.  Interestingly, cleavage at this site preserves the Atg5 
binding and CC domain and the E226 and E230 glutamates required for 
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binding to WIPI2b (Figure 1.9).  This raises the possibility that cleavage 
of Atg16L1 within the linker region may affect functions other than 
autophagy, and given the binding of the WD domain to TLR2, NOD2, 
TRIM20 and TMEM59 this may involve pathways important for 
pathogen recognition and clearance and inflammation.  
1.4 LC3 associated phagocytosis (LAP)   
The phagocytic activity (the ability to ‘’eat’’ or ‘’ingest’’) of immune 
cells, such as macrophages, dendritic cells and neutrophils is crucial for 
the normal function of the innate immunity. The engulfment of a 
pathogen results in the generation of an intracellular vesicle, called the 
phagosome, which in common with autophagosomes, fuses with 
lysosomes (Figure 1.10). Degradation in lysosomes can kill pathogens, 
allowing specialised MHC-II antigen presentation compartments to 
expose peptides derived from pathogen proteins to T-cells to increase 
immune responses (Crotzer&Blum, 2009).    
Recent studies have demonstrated that LC3, the major membrane 
protein of the autophagosome, can play a role during phagocytosis by 
an autophagyrelated pathway called LC3-associated phagocytosis (LAP) 
(Lai&Devenish, 2012). During LAP, LC3 is conjugated to the cytoplasmic 
face of the phagosomes and this may accelerate the targeting of 
phagosomes containing pathogens to lysosomes for degradation. LAP is 
activated following stimulation of Toll-like receptors, such as TLR1, TLR2, 
TLR4, and TLR6 and the engulfment of particles, which results in the 
recruitment of a subset of autophagy proteins to the phagosome. 
Although both autophagy and LAP involve the recruitment of class III 





Figure 1.9 Crohn’s disease risk allele T300A sensitizes Atg16L1 to 
caspase-3 cleavage. Crohn’s disease T300A variant is located in the 
linker region of Atg16L1 and is associated with increased sensitivity to 
caspase-3-mediated processing. The cleavage preserves the Atg5 
binding and CC domains and E226 and E230 residues required for 
interaction with WIPI2b. [Figure provided by Tom Wileman]. 
  






Figure 1.10 Pathways by which pathogens can be degraded. i) 
Autophagy targets intracellular pathogens for degradation by enclosing 
them into an LC3recruited double-membrane, an autophagosome (ii); 
(iv) The engulfment of an extracellular pathogens is termed LC3-
associated phagocytosis (LAP) and results in the formation of an LC3-
recruited single-membrane structure, a phagophore, which encapsulates 
the pathogen (v). Aurophagosomes (iii) and phagosomes (vi) fuse with a 
lysosome leading to the pathogen clearance.  conjugation systems, they 
are mechanistically distinct processes. Autophagy requires ULK1 and 
VPs34 during the formation of a pre-initiation complex, and these are 
not needed for LAP. LAP on the other hand requires a Beclin regulatory 
protein called Rubicon, UVRAG and reactive oxygen species (ROS). 






Importantly for this project Atg16L1 is required for autophagy and LAP 
(Martinez et al, 2015).   
During autophagy, the V-ATPase maintains autophagy flux by acidifying 
endolysosomal compartments and enabling the activity of the lysosomal 
hydrolases. Lysosomotropic compounds, however, inhibit autophagy 
and enhance the activation of LAP. The Na+/H+ ionophore monensin 
raises the lysosomal pH and blocks autophagy. Monensin enhances LAP 
by LC3-induced lipidation onto endolysosomal compartments, a process 
driven by osmotic imbalances within these compartments (Florey et al, 
2015).  
1.4.i Autophagy and LAP in inflammation    
Pathogen recognition receptors sense bacterial components and induce 
signal-transduction pathways which results in the production of 
inflammatory mediators, such as cytokines, interferons, and 
chemokines. The strict regulation of inflammation is crucial for the host 
because insufficient or excessive inflammation can cause damage and 
disease. It is becoming increasingly clear that intracellular degradation 
systems play an essential role in the regulation of the immune response 
by degrading inflammatory mediators (Shibutani et al, 2015).  This can 
involve degradation of pathogens, or degradation of proteins involved in 
inflammatory signalling. Both autophagy and LAP are effector 
mechanisms downstream of TLR stimulation which are involved in 
pathogen recognition and degradation, and the subsequent modulation 





1.5 Summary    
Atg16L1 is required for both autophagy and LAP but the role played by 
the WD domain of Atg16L in these processes, and the control of 
inflammation ‘in vivo’ is not known.  The observation that the T300A 
mutation associated with Crohn’s disease can lead to the release of the 
WD domain by caspase-3 suggests theWD domain may be required for 
autophagy to suppress inflammation.  Alternatively, the WD domain 
may be important for controlling inflammation through LAP, but none of 
these possibilities has been tested directly.    
Autophagy and LAP require Atg16L1 for recruitment of LC3 to 
membranes, and tissue-specific knock out of Atg16L1 would result in 
loss of both pathways.  Systemic loss of autophagy proteins, including 
Atg16L1, results in postnatal death because mice are unable survive the 
transient starvation that occurs when mice transfer from placental 
nutrition to feed on milk.  The WD domain of Atg16L1 is missing in yeast, 
even so the Atg5 binding domain and CCD (Atg5b-CCD) are sufficient for 
autophagy and viability. This made it possible that the Atg5b-CCD may 
be sufficient for autophagy in higher eukaryotes such as mice. This study 
has analysed mice expressing the Atg5b-CCD of Atg16L1, but lacking the 
linker and WD domains (Atg16L1E230) (Figure 1.12).   These mice, activate 
autophagy, survive postnatal starvation and grow at the same rate as 
littermate controls.  The mice are also fertile and provide a source of 
mice able to provide macrophages to test the role played by the Atg5b-







Figure 1.11 Possible mechanisms of autophagy and/or LAP 
inflammatory suppression in macrophages. TLR4 signalling (i) results in 
assembly of the inflammasome and conversion of proIL-1beta to IL-
1beta (ii). IL-1beta is secreted by a pathway that may involve membrane 
vesicles (iii) or transporters that could be targeted for covalent 
attachment of LC3-II and delivery to lysosomes by LAP (iv). TLR receptors 
can be removed from the plasma membrane by endocytosis (v) and 
signalling attenuated by targeting endosomes containing receptors via 
LAP (vi). Pathogens entering cells in phagosomes (vii) are targets for LAP 
resulting in rapid delivery to lysosomes for degradation (viii). At the 
same time inflammasome components (ix) and IL-1beta (x) can be 
removed from the cytoplasm by autophagy, as can pathogens that enter 






Figure 1.12 Summary of mouse phenotype with regard to Atg16L1 
domain expression. i) Full length Atg16L1 expresses both the Atg5:CC 
domain and the WD domain, therefore wild type mice are autophagy 
and LAP-positive; ii) Atg16L1E230 mice express glutamate residues E226 
and E230 which are essential for WIPI2b binding and autophagy but lack 
the WD domain and are therefore LAP-deficient; iii) Atg16L1E226 mice 
lack the E230 residue in the CC domain as well as the WD domain and 
are therefore autophagy- and LAP-deficient. [Figure provided by Tom 







1.6 Specific aims  
Aim 1.  To determine the role played the Atg5b-CCD and WD 
domain of Atg16L1 during LAP.  
Aim 2.  To determine the role played the Atg5b-CCD and WD 
domain of Atg16L1 in controlling IL-beta production by macrophages.  
Aim 3.  To determine the role played the Atg5b-CCD and WD 
domain of Atg16L1 during M1 and M2 polarisation.  
Hypothesis: 
The published observation that the T300A mutation associated with 
Crohn’s disease can lead to the release of the WD domain by caspase-3 
cleavage leads us to hypothesise that the Atg16L1E230 mouse can be used 
as a Crohn’s model. Additionally, the WD domain may be required for 








































2.1 Mouse models  
Two mouse models were used: Atg16L1E226 and Atg16L1E230 (see Chapter 
3). All mice were maintained in accordance with Home Office 
regulations under specific pathogen free conditions in individually 
ventilated cages.  Mice were weaned at approximately 3 weeks of age 
and separated by gender.  Mice were ear tagged and ear biopsy taken 
for genotying.  Maintenance animals no longer required were sacrificed 
by exposure to increasing CO2 in line with Home Office Schedule 1 
guidelines. 
2.2 Genotyping  
After the mice were bred and the new puppies were born, small ear 
biopsies were taken for genotyping. Each biopsy was lysed in 0.1 M Tris 
HCl pH=8.5 (Sigma, RES3098T-B7), 0.2M NaCl (Sigma, S7653), 0.005M 
EDTA (VWR, 60-00-4), 0.2% SDS (Sigma, L3771), 100 ug/ml proteinsase K 
(VWR, PAV3021) at 55°C overnight for tissue dissociation. Touchdown 
PCR was performed on the samples containing the lysed biopsies 
(diluted 1:10 with water), the primer sets (20 pM) (290: 5’ 
CAAATATGCCTTCAGAACTG 3’; 291: 5’ GCTGTAGTTCCAATCCCTAA 3’; 
338: 5’ TCGATGCTAGCCTACTATTC 3’) and a reagent mixture (25 uM 
dNTP mix (Thermo Fisher, R0191), home-made 10x buffer, home-made 
DNA polymerase (diluted 1:10 with water) using a standard PCR 
thermocycler (Veriti, Applied Biosystems). The PCR programme was as 
follows: 95°C for 3 min; (x10) 95°C for 45 sec, 65°C (decreases 1°C/cycle) 
for 45 sec, 72°C for 1 min; (x25) 95°C for 45 sec, 55°C for 45 sec, 72°C 
for 1 min; 72°C for 10 min; 4°C on hold. PCRs were run on a 2% agarose 
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gel, then stained in an ethidium bromide containing TAE buffer (Sigma, 
T6025) and imaged on UVP Imager.  
2.3 Bone marrow extraction  
The mice were sacrificed by cervical dislocation. The abdomen and hind 
legs were sterilised with 70% ethanol. An incision was made in the 
midline of the abdomen, then legs were cut using scissors and muscle 
was removed by a blade. The femur and the tibia were separated at the 
knee joint. The bones were cut at both ends and flushed with RPMI-
1640 (Sigma, R8758)using a 10 ml syringe and a 25gauge needle. The 
bone marrow was then passed through a cell strainer and collected into 
a 50 ml Falcon tube. The cells were then spun at 850 g at 4°C for 5 min. 
The supernatant was discarded and cell pellet was re-suspended in 14 
ml of fresh RPMI-1640. M-CSF (Peprotech, 315-02) was then added to 
the cell suspension at a concentration of 30 ng/ml and cells were 
cultured in petri dishes for 6 days in an incubator (5% CO2, 37°C). The 
medium was changed on day 3.  
2.4 Culture media and reagents  
The bone marrow-derived macrophages (BMDM) were grown in RPMI-
1640 (Sigma) containing M-CSF (30 ng/ml) (Peprotech) with 10% fetal 
calf serum (FCS) (Sigma, 12133C) and 1% penicillin/streptomycin 
(PenStrep) (Gibco by Life Technologies, 15140122) at 37°C with 5% CO2. 
Cells were detached using phosphate-buffered saline (PBS). The culture 
medium was removed and the cells were washed twice with pre-
warmed PBS. Ice cold PBS (7 ml per dish) was added to the dishes which 
were then incubated in the fridge for 30 min. Detached cells were then 
transferred into 50 ml Falcon tubes and dishes were washed with ice 
58  
  
cold PBS to collect the remaining cells. The tubes were then spun at 
850g at 4°C for 5 min. The supernatants were discarded and the cell 
pellets were re-suspended in either 1) RPMI-1640 containing M-CSF. 
Cells were counted and seeded for experiments; or 2) freezing medium 
containing 90% pre-warmed FCS and 10% DMSO (Sigma, D8418). Cells 
were frozen at -80 °C for future use.   
BMDMs were stimulated with LPS 100 ng/ml (Sigma, L4130 ) and 100 
ng/ml IFN-gamma (Peprotech, 315-05) for 24h to induce M1 
polarization, or 10 ng/ml IL-4 (Peprotech, 214-14) and 20 ng/ml IL-13 
(Peprotech, 210-13) for 24h to induce M2 polarization. To investigate 
inflammasome activation, cells were treated with 1 μg/ml LPS (Sigma) 
for 4h, followed by 150 μM BzATP (Sigma-Aldrich, B6396) for 30 min. To 
investigate IL-1beta secretion in response to TLR stimulation, BMDMs 
were treated with LPS (1 μg/ml) (Sigma-Aldrich), flagellin (10 μg/ml) 
(Sigma-Aldrich, SRP8029), CpG (10 μg/ml) (Invivogen, 1585 ), and MDP 
(10 μg/ml) (Sigma-Aldrich, A9519) to activate TLR4, TLR5, TLR9, and 
NOD2, respectively.  
2.5 Flow cytometry  
Bone marrow-derived macrophages were cultured at 5x105 cells/well in 
a 48well plate overnight at 37°C with 5% CO2 in M-CSF (30 ng/ml) 
containing RPMI-1640. Cells were detached (see ‘’Culture media and 
reagents’’) and resuspended in 0.5 ml of 5% FCS PBS. 0.5 μl of anti-
mouse CD16/CD32 antibody (Fc block antibody) (eBioscience, 14-0161-
81) was added (diluted 1:400) and the cells were incubated for 10 min. 
Anti-mouse F4/80 Antigen APC (eBioscience, 17-4801-80) and Anti-
Mouse CD11b FITC (eBioscience, 11-0112-82), 0.5 μl each, were added 
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(diluted 1:400) and the cells were incubated for 30 min in the dark. The 
samples were spun at 850 g for 5 min, washed once and re-suspended in 
600 μl of 5% FCS PBS. Unstained cells were used as a control. The cells 
were characterized using Beckman Coulter Cytoflex.  
2.6 Immunofluorescence  
BMDMs were cultured at 50 000 cells/well on microscope glass 
coverslips (13 mm, No 1, VWR, 631-0149) in 24-well plates and 
subjected to treatment time courses. The RPMI-1640 was removed, the 
cells were washed with 1xPBS and then fixed in ice cold 100% MeOH (-
20°C, 10 min) (Sigma, 322415). The cells were washed three times with 
1xPBS and blocked in 5% goat serum (Sigma-Aldrich), 0.3% Triton X-100 
(Sigma-Aldrich, 9002-93-1), 1% bovine serum albumin (BSA) (VWR) in 
PBS for 30 min. The primary antibody (Table 1) was prepared in antibody 
dilution buffer (0.3% Triton X-100 and 1% BSA in PBS). The cells were 
incubated with the primary antibody overnight at 4°C and then washed 
three times with 1xPBS, 5 min. The secondary antibody (Table 1) was 
prepared in antibody dilution buffer. The cells were incubated in the 
secondary antibody for 2h at room temperature, then washed three 
times in 1xPBS, 5 min and stained in 4’, 6-diamidino-2-phenylindole 
(DAPI) (Thermo Scientific, 62248) for 10 min at room temperature. The 
coverslips were then mounted onto microscope slides (VWR, 631-1551) 
with Fluoromount G (VWR, 100502-406) for imaging (Zeiss, Axio Vision 
fluorescence imager, 63x objective setting).  
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2.7 Analysis of IL-1beta in cell culture supernatants  
2.7.i Cell culture  
BMDMs were cultured at 80 000 cells/well in 48-well plates and either 
left in culture medium (untreated, control macrophages) or treated with 
LPS (100 ng/ml) (Sigma-Aldrich) for 4h and BzATP (150 μM) for 30 min. 
The supernatants were then collected and IL-1beta levels were 
measured using Luminex (eBioscience).  
2.7.ii Luminex Multiplex Assay  
Concentrated 50x IL-1beta Simplex beads (eBioscience, EPX01A-26002-
901) were diluted in water at a final concentration 1x. The beads were 
then vortexed for 30 sec. 50 μl of the magnetic beads attached to 
antibodies were added to the appropriate wells of a 96-well flat bottom 
plate and incubated for 2 min to allow their accumulation on the bottom 
of each well. The wells were then washed with 120 μl of wash buffer 
(Hand-Held Magnetic plate washer was used for the washing steps) 
(eBioscience). The IL-1beta standard was diluted in culture medium 
according to manufacturer’s protocol to prepare the top concentration 
(4 800 pg/ml). 4-fold serial dilutions were made to create the standard 
curve for a total of 7 points. 50 μl of standards/samples were added to 
the beadcontaining wells. The plate was sealed and incubated with 
shaking for 2h at room temperature. The wells were washed 3 times 
with 120 μl of wash buffer. 25 μl/well of IL-1beta detection antibody was 
added, plates were sealed and incubated with shaking for 30 min at 
room temperature. After 3x120 μl washes with wash buffer, 50 μl/well 
of Streptavidin-PA was added and plates were sealed and incubated 
with shaking for 30 min at room temperature.  
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Once again, the wells were washed 3x120 μl of wash buffer after which 
120 μl/well of reading buffer was added. The plate was sealed and 
incubated with shaking for 5 min at room temperature, and then read 
on Luminex®100/200.  
2.8 Analysis of IL-1beta in murine serum samples  
2.8.i In vivo LPS challenge  
Mice were injected intraperitoneally with either PBS (control) or LPS (10 
mg/kg) (Sigma, L2630) and blood samples were collected 90 min post 
injection. The whole blood was allowed to clot at room temperature for 
20 min. To remove the clot, the samples were then spun at 2000 g at 
4°C for 10 min. The resulting supernatant (blood serum) was transferred 
to a clean Eppendorf and used for Luminex analysis of IL-1beta levels 
(see Analysis of IL-1beta in cell culture supernatants).  
2.9 ProIL-1beta ELISA  
2.9.i Preparation of lysates from cultured bone marrow-derived 
macrophages  
BMDMs were cultured at 80 000 cells/well in a 48well plate overnight at 
37°C with 5% CO2 in M-CSF (30 ng/ml) containing RPMI-1640. They were 
then either left in the culture medium (untreated, control macrophages) 
or treated with LPS (100 ng/ml) (Sigma-Aldrich) for 24h. After the 
incubation, the medium was removed and the cells were washed with 
PBS. 100 μl of ice cold ProcartaPlex cell lysis buffer (eBioscience, EPX-
99999-000) was added to each well and incubated for 5 min. The cells 
were then scraped, transferred to a clean Eppendorf tube and spun at 
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14 000 g at 4°C for 10 min. The supernatants were transferred to a clean 
Eppendorf and assayed or stored at -80°C.  
2.9.ii Enzyme Linked Immunosorbent Assay (ELISA)  
ELISA was conducted according to manufacturer’s protocol (ELISA 
Ready-SetGo, eBioscience, discontinued). In brief, Corning Costar (9018) 
ELISA plates were coated with 100μl of proIL-1beta capture antibody in 
1xcoating buffer. The plates were sealed and incubated overnight at 
4°C. The wells were then aspirated and washed three times with 250 μl 
wash buffer. The residual liquid was removed by blotting the plates on 
absorbent paper. To block the wells, 200 μl of 1xELISA Diluent was 
added and the plates were incubated at room temperature for 1h. The 
wells were aspirated and 100 μl of each sample was added per well. The 
plates were sealed and incubated at room temperature for 2h. The wells 
were aspirated and washed 5 times with 250 μl wash buffer. After 
adding 100 μl/well of biotinylated detection antibody, the plates were 
sealed and incubated at room temperature for 1h. The wells were 
aspirated and washed 5 times with 250 μl wash buffer. 100 μl/well of 
Avidin-HRP was added and the plates were incubated at room 
temperature for 30 min. The wells were aspirated and washed 7 times 
with 250 μl wash buffer. 100μl/well of TMB solution was added and the 
plates were incubated at room temperature for 15 min. 50 μl/well of 
stop solution was added and plates were read at 450 nm using (the 
values were corrected to the background of 570 nm). Mouse proIL-
1beta recombinant protein was used to create a standard curve. The 
standard was diluted according to manufacturer’s protocol 
(eBioscience) to prepare the top concentration (3 000 pg/ml). 2-fold 
serial dilutions were made to create the standard curve for a total of 8 
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points. 100 μl/well of each standard was added to the appropriate wells. 
The concentration of proIL-1beta in each sample was calculated using 
the standard curve.  
2.10 Caspase-Glo® 1/8 Inflammasome Assay  
BMDMs were cultured at 50 000 cells/well in a 96-well plate overnight 
at 37°C with 5% CO2 in M-CSF (30 ng/ml) containing RPMI-1640. They 
were then either left in culture medium (untreated, control 
macrophages) or treated with LPS (1 μg/ml) for 4h which was followed 
by a 30 min treatment with BzATP (150 μM) (Sigma-Aldrich). The plate 
was then removed from the incubator and allowed to equilibrate at 
room temperature for 5 min. 100 μl of Caspase-Glo® 1/8 reagent 
(Caspase-Glo® 1 buffer was added to ZWEHD substrate; Caspase-Glo® 8 
buffer was added to Caspase-Glo® 8 substrate) (Promega, G9951 and 
G8200) was added to each well and the contents were mixed by using a 
plate shaker at 500 rpm for 30 sec. The plate was incubated at room 
temperature for 1h and read at 560 nm using a Wallac plate-reading 
luminometer. Blank reactions (containing culture medium but no cells) 
were used to measure the background luminescence associated with 
the culture medium and Caspase-Glo® 1/8 reagent. The values for the 
blank reactions were subtracted from those obtained for the 
experimental cells.   
2.11 Mouse proIL-1beta _pcDNA3.1+N-eGFP  
Mouse proIL-1beta _pcDNA3.1+N-eGFP was generated by GenScript. 
This plasmid contains full length proIL-1beta tagged at the N-terminus 
with enhanced green fluorescent protein (eGFP).    
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2.11.i Starter culture preparation and plasmid isolation  
The proIL-1beta plasmid (4 μg) was re-suspended in 40 μl of water. After 
a brief vortex, 4 μl of the plasmid were added to 50 μl of DH5α E.coli. 
The sample was incubated on ice for 30 min, heated at 42°C for 50 sec, 
incubated on ice for 2 more minutes, then added to 900 μl of SOC 
medium (Invitrogen, 15544034). The medium was incubated with 
shaking at 37°C for 2h. LB agar plates (with ampicillin, 100 μg/ml) were 
spread with 100 μl of the SOC medium and incubated overnight at 37°C 
for 14-16h. A single colony was selected and inoculated in 150 ml of 
liquid LB medium with ampicillin (100 μg/ml). After a 14-16h incubation 
at 37°C in shaking condition, the LB was transferred into a 50 ml Falcon 
tube which was then spun at 6000g for 15 min. The supernatant was 
discarded and the plasmid isolation was conducted according to the 
manufacturer’s protocol (Macherey-Nagel). In brief, the pellet was re-
suspended in 8 ml of resuspension buffer+Rnase A (NucleoBond®Xtra 
Midi kit, 740410-10). After a brief vortex, 8 ml of lysis buffer was added 
to the suspension. The tube was incubated at room temperature for 5 
min. NucleoBond®Xtra column was equilibrated with 12 ml of 
equilibration buffer which was allowed to empty by gravity flow. 8 ml of 
neutralization buffer was added to the suspension and was mixed by 
inverting the tube. The lysate was loaded onto the column which was 
then washed with 5 ml of equilibration buffer. The column filter was 
removed and the column was washed with 8 ml of wash Buffer. The 
plasmid DNA was eluted with 5 ml of pre-heated elution buffer and 
collected in a 50 ml Falcon tube. 3.5 ml of room temperature 
isopropanol was added to precipitate the DNA. The sample was 
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vortexed and spun 15 000 g at 4°C for 30 min. The supernatant was 
removed and 2 ml of room temperature 70% ethanol was added to the 
pellet. The sample was spun at 15 000 g at room temperature for 5 min. 
The ethanol was discarded and the pellet was allowed to air dry for 10 
min. The plasmid DNA pellet was re-suspended in 300 μl of sterile water. 
The concentration was measured using a nanodrop spectrometer.  
2.11.ii Restriction digest  
The mouse proIL-1beta pcDNA3.1+N-eGFP plasmid (300 ng) was 
digested using KpnI and EcoRI (Figure 2.1). The digestion was performed 
in water bath at 37°C for 40min. The plasmid was run on a 1% agarose 
gel (restriction digestion conducted by GenScript).  
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Figure 2.1: Pro-IL1β-GFP plasmid map and restriction digest validation 
of plasmid. (i) A cartoon of the plasmid and the gene of interest pro-IL1β 
ligated into plasmid DNA using KpnI and EcoRI; (ii) 300ng plasmid DNA, 
lane 1, was ran on a 1% agarose gel, 300ng plasmid DNA after digestion 
using KpnI and EcoRI restriction enzymes, lane 2. Lane M is a base-pair 
ladder for size, expanded version shown in (iii).  Lane 2 shows the gene 
of interest approximately 800bp (lower band) and empty plasmid 
7000bp (upper band).  
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2.11.iii HEK293A cell culture  
Human Embryonic Kidney 293 cells (HEK293A) (Thermo Fisher, R70507) 
were chosen to use with the mouse proIL-1beta pcDNA3.1+N-eGFP 
plasmid due to their high transfection efficiency. The cells were cultured 
in high glucose Gibco™ DMEM (Fisher Scientific, 41965062) in T75 flasks 
and split 1:3 every 2 to 3 days.   
2.11.iv Mouse proIL-1beta pcDNA3.1+N-eGFP plasmid transfection  
HEK293A cells were cultured at 15 000 cells/well on glass coverslips (13 
mm, No 1, VWR) in a 24-well plate. The transfection was conducted 
using Lipofectamine® LTX with Plus™ reagent (ThermoFisher Scientific, 
15338100) according to the manufacturer’s protocol. In brief, the 
following recipe was followed (volumes indicated/well): 1.4 μl of 
Lipofectamine was mixed with 50 μl of Optimem in a 1.5 ml Eppendorf. 
In a separate 1.5 ml Eppendorf 1.05 μl of plasmid DNA (2 μg) was mixed 
with 0.65 μl of Plus reagent and 50 μl of Optimem. The contents of the 
two tubes were mixed, vortexed and incubated at room temperature for 
10 min. 100 μl of the mixture was added per well.  
The plate was incubated at 37°C with 5% CO2 for 24h.  
2.12 Protein analysis  
2.12.i Cell lysis  
For the protein expression analysis, BMDMs were cultured at 500 000 
cells/well overnight at 37°C with 5% CO2 in M-CSF (30ng/ml) containing 
RPMI-1640 in a 12 well-plate, and subjected to treatment time courses. 
The cells were washed once with 1xPBS which was then discarded. 30 μl 
of Tissue Protein Extraction Reagent (T-PER) (Thermo Fisher, 89842) was 
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added per well. The cells were then scraped and the cell lysates were 
transferred to clean Eppendorf tubes. The lysates were incubated on ice 
for 30 min and then centrifuged at 16 000 g at 4°C for 10 min. The 
supernatants were transferred to clean Eppendorf tubes and stored at -
80°C or used for Western blotting.  
2.12.ii Bradford assay  
The Bradford assays were conducting using the Bio-Rad protein kit II 
(Bio-Rad, 5000002). A bovine serum albumin (BSA) standard was diluted 
according to the manufacturer’s protocol (Bio-Rad) to prepare the top 
concentration (150 μg/ml) which was then used to create the standard 
curve for a total of 7 points. 10 μl of each BSA standard were loaded in a 
96-well plate. The samples were diluted 1:10 with nuclease-free water 
and 10 μl of each were used for the assay. The Bio-Rad protein assay dye 
reagent was made up in water at a dilution of 1:5. 190 μl of the dye 
were added to both standards and samples to a total volume of 200 
μl/well. The plate was incubated at room temperature for 5 min and 
read on BMG Omega reader (595nm). The sample volumes to be loaded 
onto the Western blotting gels were calculated to make 10 μg/μl.  
2.12.iii Western blotting  
Equal volumes of protein sample and RunBlue LDS sample buffer 
(Expedeon, B31010) were mixed and heated at 93°C for 4 min. The Blue 
SDS run buffer (Expedeon, NXA05160) was diluted 1:8 in water. Precast 
4-12% SDS gels (Expedeon, NXG41212) and All Blue standards (Bio-Rad, 
1610373) were used for the assay. The gels were run at 140V for 90 min. 
The samples were transferred onto nitrocellulose membranes (Bio-Rad) 
by wet transfer containing 25 mM Tris base, 190 mM glycine, 20% 
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methanol and 0.05% SDS. The transfers were run at 200mA at 4°C for 85 
min. The membranes were blocked for 1h in 5% skim milk (Sigma, 
70166) Tris-buffered saline and Tween® 20 (Sigma-Aldrich, P9416) 
(TBST) at room temperature. The blocked membranes were stained with 
primary antibodies in 3% skim milk (Table 1) overnight at 4°C. The 
stained membranes were washed in TBST 5x5 min at room temperature, 
then stained with secondary antibodies (Table 1) at room temperature 
for 2h. The membranes were washed in TBST 5x5 min and PBS 2x1 min, 






Table 1. Primary and secondary antibodies used for 




2.13 Gene expression analysis  
2.13.i RNA extraction   
BMDMs were cultured at 500 000 cells/well overnight at 37°C with 5% 
CO2 in M-CSF (30ng/ml) containing RPMI-1640 in a 12 well-plate and 
treated according to the experimental needs. The cells were washed 
once with 1xPBS which was then discarded. 100 μl Trizol reagent 
(Ambion by Life Technologies, 15596026) was added to each well. The 
cells were scraped and the samples were transferred to clean Eppendorf 
tubes. 20 μl chloroform was added to each sample to help the 
homogenization. The tubes were shaken vigorously for 15 sec, incubated 
at room temperature for 2 min, and then spun at 12 000g at 4°C for 15 
min. The aqueous phase of the samples was removed and placed into a 
new tube. 50 μl 100% isopropanol was added to the samples which were 
then incubated at room temperature for 10 min and spun at 12 000g at 
4°C for 10 min. The supernatants were discarded and the RNA pellets 
were washed with 100 μl 75% ethanol. The samples were vortexed and 
spun at 7 500g at 4°C for 5 min. The wash was discarded and the pellets 
were air dried for 10 min, then re-suspended in 15 μl Rnase-free water 
and incubated in a heat block at 57°C for 15 min.   
2.13.ii RNA clean-up  
The RNA samples were cleaned using Rneasy MinElute cleanup kit 
(Qiagen, 74204). The sample volume was adjusted to a volume of 100 μl 
with Rnase-free water. 350 μl buffer RLT and 250 μl 100% ethanol were 
added. The samples were then mixed well, transferred to an Rneasy 
MinElute spin column placed in a 2 ml collection tube, and spun at 10 
000 g at room temperature for 15 sec. The wash was discarded and 500 
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μl buffer RPE was added to the spin column. The samples were spun at 
10 000 g at room temperature for 15 sec, 500 μl 80% ethanol was added 
each of them, followed by a 2 min spin at 10 000 g. The flow-through 
was discarded and the columns were spun again at full speed for 5 min 
to dry the spin column membranes. The Rneasy MinElute spin columns 
were placed in new 1.5 ml collection tubes. 14 μl Rnase-free water was 
added to the column membranes, then the tubes were spun at full 
speed for 1 min to elute the RNA.  
A nanodrop spectrometer was used to measure the RNA concentration.   
2.13.iii Reverse transcription (cDNA synthesis)  
The reverse transcription was done according to Table 2. The mixture 
was heated at 65°C for 5 min and then chilled on ice. 4 μl 5xFirst strand 
buffer and 2 μl 0.1M DTT were added to the mixture which was then 
incubated at 25°C for 2 min. 1 μl Superscript II was added, followed by a 
2-hour incubation at 42°C and a 15-minute incubation at 70°C.  
2.13.iv Primer design and optimization  
The primers were designed using Primer3 software and purchased from 
Sigma-Aldrich unless otherwise stated (Table 3).   
Gradient PCR was performed to determine the optimum annealing 
temperature of each primer set: initial denaturation: 95°C for 30 sec; 
cycling stage (x40): 95°C for 5 min, temperature gradient for 15 sec, 
72°C for 10 min. The PCR products were run on a 2% agarose gel 
containing ethidium bromide (Figure 2.2i). After the optimum annealing 
temperature was determined, the qRT-PCR amplification efficiency was 
estimated which indicates the rate at which the PCR amplicon is 
generated. A standard curve and a 2-fold dilution   
73  
  
   
 Table 2. Reverse transcription reagent mixture.    
Table 3. Primers used for qRT-PCR   
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series of cDNA were used to verify the efficiency of the PCR reaction 
(Figure 2.2ii). Only primer sets with efficiencies between 90% and 110% 
were used for qRT-PCR (Figure 2.2iii).   
2.13.v qRT-PCR  
qRT-PCR was carried out using 2x qPCRBIO SyGreen mix (PCR 
Biosystems, PB20.11-05) (Table 4).  
The real-time PCR programme was as follows: holding stage: 50°C for 2 
min, followed by 95°C for 10 min; cycling stage (x35): 95°C for 15 sec, 
followed by the specific primer annealing temperature (Table 4) for 45 
sec; melt curve stage: 95°C for 15 sec, 60°C for 1 min, 95°C for 30 sec 
and 60°C for 15 sec. The melt curves were analyzed to determine if the 
qRT-PCR had produced single, specific product (Figure 2.2iv). The gene 
expression values were calculated using the relative copies method and 
normalized to 18S. The PCR was carried out in a 7500 Real-Time PCR 
System (Applied Biosystems, Grand Island, NY).   
2.14 Seahorse  
The Seahorse XFp metabolite analyzer was used to measure oxygen 
consumption (OCR) and proton production (ECAR) from BMDMs isolated 
from wild type or mutant mice. The flux plate (Figure 2.3) is loaded with 
specific inhibitors in each port (four ports above each well) that allow 
selective application of either substrates or inhibitors of glycolysis or 
oxidative phosphorylation. The flux plate sits above the cell culture plate 
that has eight wells containing adherent cells in six wells, two wells are 
used as control wells. The substrates and inhibitors are injected at 
specific time points, to examine their effect upon cell metabolism. For 
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example, experiments lasted approximately 100 minutes with detection 
of either OCR or ECAR every 12 minutes, appropriate substrates or 
inhibitors were injected sequentially at time points 20, 45 and 70 
minutes thereby allowing approximately 25 minutes to determine any 
effect. The Seahorse detects changes in either OCR or ECAR by 
fluorescent sensor probes that run down through the flux plate in close 
proximity to the adherent cell layer. The Seahorse XF Cell Mito Stress 
Test (Agilent, 103015-100) kit was used to examine different parameters 
of respiration; basal respiration, proton leak and ATP production, whilst 
the Seahorse glycolysis stress test (Agilent, 103017-100) was used to 








Figure 2.2. Example validation of primer set to be used for qPCR. (i) 
Annealing temperature was determined using endpoint PCR over the 
indicated annealing temperature range (60-64°C) and products ran on a 
1% agarose gel. Thereafter, the primer efficiency in a qPCR (ii) reaction 
was calculated at the annealing temperature (60°C) using serial dilutions 
of cDNA and plotting the Ct value versus Log concentration, the slope of 
the curve (3.3) was used to determine the efficiency (100.8%). The Ct 
values of serially diluted cDNA was derived from amplification curves 
(iii). Finally, the melt curve was examined (iv) to ensure a single product 
(red) for the primer set and no product (also see (i)) in the no-template 
control (green) sample.  
  
        
     Table 4. qRT-PCR reagent mixture.    
  




Figure 2.3 Seahorse Flux and Cell plates used in mitochondrial or 
glycolysis stress tests. (i): Flux plate (green) with injection ports sits on 
top of the cell culture plate (bottom clear). (ii) Zoom in schematic of the 
Seahorse well plate and sensor for detection of oxygen or protons at the 
detection probe tip, using proprietary fluorescence technology, and is 
utilised during the mitochondrial or glycolytic stress tests respectively. 
These fluorescence measures are then used to calculate separate areas 




2.14.i Glycolysis stress test  
The glycolysis stress test measured the basic metabolic profile of the 
BMDM cells derived from wild type and Atg16L1E230 and Atg16L1E226 
mutant mice. Glycolytic activity was determined from the extracellular 
acidification rate (ECAR, Figure 2.4).  
The indicated injection of saturating amounts of glucose (10mM, Figure 
2.4) enabled glycolysis to be determined through its conversion from 
glucose to pyruvate (Figure 2.5) by the subsequent detection of protons 
or extracellular acidification (ECAR). Injection of oligomycin (1μM), 
allowed the glycolytic capacity to be determined and indicated the 
maximum rate of glycolysis as oxidative phosphorylation would have 
been blocked and thus cells were forced to utilise glycolysis to make 
ATP. It further enabled the glycolytic reserve to be calculated by 
subtracting glycolysis from glycolytic capacity, the glycolytic reserve 
indicated a cells ability to respond to an energetic demand (stress 
event).  
The final injection of 2-deoxyglucose (50mM), a competitive inhibitor of 
glucose hexokinase, competitively blocks glycolysis, and allowed the 






            
 
Figure 2.4 Example protocol of the glycolysis stress test. Schematic of 
the time course of the glycolysis stress test showing changes in ECAR in 
response to addition of; glucose (10mM) at time point 20 minutes, 
oligomycin (1μM) at time point 45 minutes and 2-deoxyglucose (50mM) 
at time point 70 minutes. These data allow measures of glycolysis (blue 
area), glycolytic capacity (green area) and glycolytic reserve (dark green 
area) to be determined [Taken from Agilent Technologies].  
  





                     
 
Figure 2.5 Abbreviated schematic of glycolysis. During glycolysis glucose 
is utilised as a substrate to generate 2ATP, generating protons which are 
detected by the probe and plotted as ECAR. Here glucose is applied to 
initiate ATP production, oligomycin is added to remove OXPHOS to force 
the cells to utilise glycolysis alone as an ATP source and finally 2-DG is 
added to block the first enzyme (glucose hexokinase) in the glycolytic 
pathway thereby allowing non-specific acidification to be determined 





2.14.ii Mitochondrial stress test   
The oxygen consumption rate (OCR) was determined as a measurement 
of oxidative phosphorylation (OXPHOS, Figure 2.6). Oxidative 
phosphorylation (OXPHOS) is the generation of a proton gradient by 
electron transport chain subunits, this proton gradient is then utilised to 
power the production of ATP (Figure 2.7).  
Basal respiration indicates (Figure 2.6) normal energetic demand of a 
cell under basal conditions. The decrease in oxygen consumption in 
response to oligomycin (1μM) indicated the portion of respiration being 
utilised to drive ATP production. Subsequent injection of the un-coupler 
FCCP (1μM), that collapses the proton gradient, forces the cells into 
maximum oxygen consumption by complex IV (as if an energy demand 
or stress has been imposed), giving a measure of maximal respiration 
through the consumption of available substrates (e.g. fats, amino acids, 
sugars). This further allows the spare respiratory capacity to be 
calculated by subtracting maximal respiration from basal respiration, 
which indicated the ability of a cell to respond to an energetic demand 
whilst indicating how close a cell is already to that theoretical maximum 
respiration. Injection of rotenone and antimycin-A (0.5μM) block all 
remaining electron transport chain function and indicated the oxygen 
consumption that was non-mitochondrial. The difference between the 
non-mitochondrial oxygen consumption and oxygen consumed during 
ATP production allowed the proton leak to be calculated, a higher 
proton leak indicated greater mitochondrial damage.  
At the experiment end, the six wells of the tissue culture plate were 
washed twice with PBS and thereafter 20μl lysis buffer was applied. The 
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cell culture plate was left on ice for 30 minutes before each well being 
scrapped and the   
               
Figure 2.6 Example protocol of the mitochondrial stress test. Schematic 
of the time course of the mitochondrial stress test showing changes in 
mitochondrial OCR in response to sequential addition of; oligomycin 
(1μM), FCCP (1μM) and finally rotenone combined with antimycin-A 
(0.5μM) at time points 20, 50 and 80 minutes respectively. These data 
allow the determination of basal respiration (blue area), ATP production 
(magenta area), proton leak (purple area), maximal respiration (green 
area) and spare respiratory capacity (dark green area) [Taken from 
Agilent Technologies].  
  
    





Figure 2.7 Schematic of the electron transport chain. The scheme 
shows the key sites of proton pumps within the electron transport chain 
and the location of mitochondrial stress test antagonist action upon 
each electron transport chain subunit. Oligomycin blocks complex V 
(ATP synthase), FCCP is an uncoupler and collapses the proton gradient 
whilst rotenone a complex I inhibitor and antimycin-A a complex III 
inhibitor shut down the remaining mitochondrial respiration [Taken 












lysis buffer placed in an Eppendorf tube for bath sonication at 4°C for 5 
minutes. Thereafter, the tubes were centrifuged for 8 minutes at 
11000g, the supernatant being taken and placed in a fresh tube for 
subsequent protein determination using the Bradford method (see 
western blot section for Bradford description).  
Experiments were undertaken in triplicate (or as indicated) to enable 
average data to be calculated, plotted and analysed using Student’s T-
Test. The Seahorse report generator automatically calculates the 
required respiratory parameters for both the glycolysis and 
mitochondrial stress tests using the supplied Wave software (Version 
2.4.0; Agilent Technologies). The generated Wave report was exported 
to Excel where the data for each test and area of interest was pooled 
and averaged for subsequent plotting. The p values < 0.05 were 
considered statistically significant.  
2.15 Statistical analysis  
The results were derived from three independent experiments unless 
otherwise stated. The statistical analysis was done with GraphPad Prism 
v5 using one-way ANOVA unless otherwise stated. The p values < 0.05 
were considered statistically significant (* < 0.05; ** < 0.01; *** < 0.001; 
















Chapter 3   












3.1 Introduction and aims  
Mammalian Atg16L1 is a key protein that regulates autophagosome 
biogenesis. Defects in Atg16L1 are associated with susceptibility to 
inflammatory bowel disease, as well as colorectal cancer and chronic 
obstructive pulmonary disease (Chen et al, 2015). Atg16L1 consists of an 
N-terminal region which binds Atg5 and a coiled-coil domain (CCD) 
which mediates self-oligomerization and acts as interaction site for 
different proteins involved in the autophagy pathway, such as WIPI2b 
(Mizushima et al, 2003) Atg16L1 also contains a structural motif of 40 
amino acids (often terminating in a Trp-Asp (W-D) dipeptide), the WD 
domain which is exclusively present in mammals. The absence of this 
domain in yeasts indicates that it is not crucial for bulk autophagy. This 
has been demonstrated by Mizushima and colleagues (2003) in a 
truncated mouse Atg16L1 variant in which the absence of the WD 
domain did not affect canonical autophagy.   
It has been reported that defects in the LAP pathway resulting from the 
absence of key protein components, such as rubicon and NADPH 
oxidase-2, lead to increased inflammatory cytokine production, thus 
implicating LAP in the control of inflammation (Martinez et al, 2016). 
Other studies suggest that it is autophagy that suppresses and regulates 
inflammasome activation and limits the production of pro-inflammatory 
cytokines. It has been shown that macrophages lacking the CC domain of 
Atg16L1 produce and secrete increased levels of IL-1beta and IL-18 
when stimulated with LPS, lipopolysaccharide, which mimics bacterial 
infection (Saitoh et al, 2008).   
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To further investigate the functions of the CCD and WD domains of 
Atg16L1 in the innate immunity, appropriate mouse models had to be 
established. That was done by Julia Maryam Arasteh during the course 
of her PhD. As already mentioned, the Atg16L1E226 model, carries a stop 
codon after glutamate 226 which prevents the expression of glutamate 
at position 230 and the binding to WIPI2b, a modulator of 
autophagosome elongation through interaction with Atg16L1 (Dooley et 
al, 2014). The Atg16L1E230 model carries a stop codon at the end of the 
CC domain which contains glutamate residues E226 and E230 which are 
required for WIPI2b binding. Therefore, both mouse models lack the WD 
domain of Atg16L1. Having these two models, we could investigate the 
role of the Atg16L1 domains in inflammation and innate immunity.   
After the mouse models were established, mice had to be genotyped for 
their genetic make-up to be verified. Heterozygous mice were not used 
for experiments. Homozygous as well as littermate control mice were 
included in the studies.   
3.2 Atg16L1E226 and Atg16L1E230 genetic background  
Atg16L1 is the mammalian homologue of the yeast Atg16. The only 
structural difference between the two is the absence of the WD domain 
in the yeast equivalent which only consists of 150 amino acids (aa). In 
the mouse genome Atg16L1 is located on chromosome 2 and consists of 
19 exons which code for 623 aa. The CC domain of Atg16L1 spans 79-
230 aa and includes the first 6 exons of the gene, whereas the WD 
domain spans 320-607 aa and includes exons 10-19 (Uniprot).   
To establish a mouse model which does not have the WD domain but 
has an intact CC domain (Atg16L1E230), stop codons had to be inserted. 
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Since exon 6 contains the last amino acids which encode the CC domain, 
two stop codons as well as a neomycin cassette were introduced after 
exon 6 to terminate the production of the linker region and the WD 
domain (Figure 3.1). In the  
Atg16L1E230 mouse, the CC domain contains glutamate residues E226 
and E230 which are involved in the interaction with WIPI2b. In the 
Atg16L1E226 mouse model, the TAGTAG stop codons were introduced at 
position 226 of the CC domain to remove residues E226 and E230 and 
block the binding of the resultant form of Atg16L1 with WIPI2b and 
disrupt autophagy (Figure 3.1).   
3.2.i Mouse genotyping  
The genetic make-up of the mice had to be verified before they were 
sacrificed and used for experiments. As already mentioned, 
heterozygous mice were not included in the studies but were used for 
breeding. To classify the mice as control wild type, heterozygous or 
mutant, we genotyped DNA samples extracted from ear biopsies (as 
described in Methods). The primers used for the PCR reactions were 
designed to amplify specific regions adjacent to exon 6 giving different 
sized products depending on the mouse genotype (as described in 
Methods) (Figure 3.2). The first primer set binds to the intronic 
sequences which are adjacent to exon 6, thus amplifying the whole 
exon. In case of a wild type sequence (Figure 3.2i), the size of the 
amplicon is 291 bp because it only contains exon 6 and small parts of the 
adjacent introns. In the presence of stop codons, the product size is 639 
bp because the sequence contains a neomycin cassette which is inserted 
straight after exon 6 but before the reverse primer site (Figure 3.2ii and 




Figure 3.1 Atg16L1 WT, Atg16L1E226 and Atg16L1E230 genetic 
background. i) The CCD of the wild type Atg16L1 contains both 
glutamate residues E226 and E230 which are involved in WIPI2b binding. 
The control mice also have the WD domain which attached to the CCD 
via a linker region; ii) Atg16L1E230. Two stop codons and a neomycin 
cassette are introduced after exon 6 of the CC domain which retains the 
E226 and E230 residues involved in the WIPI2b binding. The WD domain 
of Atg16L1 is absent; iii) The CCD of Atg16L1E226 is missing the glutamate 
residue at position 230 which blocks the binding with WIPI2b. The WD 
domain of Atg16L1 is absent. Atg16L1E226 and Atg16L1E230 mouse models 
were established by Julia Maryam Arasteh. 
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have both the 291 and the 639 (Figure 3.2iv and 3.2v).  To distinguish 
between the Atg16L1E226 and Atg16L1E230, an extra primer set was used. 
The CCD of the Atg16L1E230 mouse contains an extra 4 amino acids. Since 
each amino acid is encoded by 3 nucleotides, the DNA sequence of 
Atg16L1 in the Atg16L1E230 mouse model is 12 nucleotides longer than 
the one in the Atg16L1E226. To distinguish between the two mouse 
models, the reverse primer of the second primer set (290x338) binds to 
the DNA sequence of exon 6 which is present in the Atg16L1E230 but 
absent in the Atg16L1E226 (Figure 3.2iii). Thus, in case of an Atg16L1E230 
animal, the PCR reaction shows a product with an amplicon size of 179 
bp, but no amplification is observed for Atg16L1E226 (Figure 3.2v). Once 
their genotype was verified, the appropriate mice were sacrificed and 
bone marrow was extracted from the lower legs (femurs and tibias) for 
the experimental purposes described in this thesis.  
3.2.ii Determination of the effect of genotype upon phenotype by 
performing protein expression analysis 
To verify the genotype of the mice, bone marrow-derived macrophages 
were used to analyse the protein expressed by wild type and mutant 
Atg16L1 mice. Cells were probed for Atg16L1 as well as LC3, a key 
protein involved in autophagosome formation and an accepted 
autophagosome marker. Macrophages were also stained for LC3 after 
HBSS starvation to evaluate autophagy.   
As expected, full length Atg16L1 was observed in the wild type cells but 
not in the Atg16L1E226 or Atg16L1E230 which only expressed the CCD of 
the protein (Figure 3.3i). As already described, both Atg16L1E226 and 
Atg16L1E230 lack the WD domain but have an intact CCD. The stop codon 
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after glutamate 226 does not compromise the antibody binding and the 
CC domain can still be detected but after longer exposure.   
3.3 Ability of Atg16L1E226 and Atg16L1E230 to generate autophagosomes  
As already described, mammalian LC3 is an essential component of 
autophagy. Following synthesis, LC3 is cleaved by cysteine protease-
Atg4 to form LC3-I which is dispersed throughout the cytoplasm. In 
response to starvation, LC3-I is conjugated to phosphatidylethanolamine 
to form LC3-II which binds the newly formed autophagosomes and is a 
marker for autophagosome formation. Figure 3.3ii shows generation of 
the 14 kDa LC3-II following starvation of bone marrow-derived 
macrophages from control and Atg16L1E230 mice but the 14kDa band was 
not produced in macrophages from Atg16L1E226 macrophages expressing 
the CCD that lacks protein residues required for WIPI2b binding. Unlike 
the control and Atg16L1E230 macrophages which showed LC3-I/LC3-II 
conversion, Atg16L1E226 cells presented with accumulation of LC3-I, 
probably due to compromised autophagy which reduces degradation of 







Figure 3.2 Annealing sites of primers 290, 291 and 338 used for 
genotyping.i) Full length Atg16L1. Primers 290 and 291 bind to the 
intronic sequences adjacent to exon 6 and result in a 291 bp product; ii) 
Atg16L1E226 mouse. The insertion of a neomycin cassette after exon 6 
results in the generation of a 639 bp product; iii) Atg16L1E230 mouse. An 
extra 338 primer which binds to the sequence of exon 6 which is present 
in the Atg16L1E230 but absent in the Atg16L1E226 is used to distinguish 
between the two. An Atg16L1E230 animal results in the generation of a 
















3.4 Comparison of major phenotypes of Atg16L1E226 and Atg16L1E230 
mice  
It has been shown that autophagy-deficient Atg5-/- mice show minimal 
abnormalities at birth but have lower body weight than that of wild-type 
mice. However, although they do not display any abnormal phenotypes, 
Atg5-/-  neonates died within 1 day of delivery (Kuma et al, 2004). A few 
studies have reported similar neonatal lethality in Atg3-/-, Atg7-/-, 
Atg12-/-, and Atg16L1/- mice (Komatsu et al, 2005; Malhotra et al, 2015; 
Sou et al, 2008; Saitoh et al, 2008). Similarly, the autophagy-
compromised Atg16L1E226 mice were smaller compared to control and 















            
 







Figure 3.3 Role played by the Atg5 binding and CC domains of Atg16L1 
in autophagy. BMDMs were cultured in growth medium (fed) or HBSS 
(starved) to induce autophagy. Cell lysates were then blotted with the 
antibodies to detect i) Atg16L1 or ii) LC3. Actin was used as a control. 
(n=3).  
actin   42 
LC3-I   




lethality was observed. A recent study by Yoshii and colleagues (2016) 
has demonstrated that re-expression of Atg5 in the brain is sufficient to 
rescue Atg5-/- mice from neonatal lethality, suggesting that neuronal 
dysfunction is the main cause of death of Atg5-/- mice. Interestingly, 
although rescued from lethality, these mice presented with various 
anatomical abnormalities, such as enlarged liver, spleen, and lymph 
nodes, with varying inflammatory changes. Abnormalities were also 
observed in the reproductive organs (Yoshii et al, 2016). In this study, a 
comparison of major phenotypes of Atg16L1E226 and Atg16L1E230 was 
performed. Whole body weight of sacrificed mice was measured (Figure 
3.4). The adult Atg16L1E230 mice containing an intact CC domain and 
capable of starvation-induced autophagy had an average body weight of 
28 grams similar to littermate controls (25 grams).  The Atg16L1E226 mice 
were some 25% smaller at 18 grams.  Interestingly, the liver was 
enlarged in the Atg16L1E226 model weighing on average 2.5 grams 
compared to 1.5 grams for Atg16L1E230 and littermate controls, which 
was indicative of possible inflammation (Figure 3.4). No obvious size 
differences were observed in the rest of the organs, such as brain, heart, 
lungs, kidneys or intestines. However, the autophagy-compromised 
Atg16L1E226 mice were infertile and therefore only heterozygous mice 
were used for breeding. The Atg16L1E230 mice were fertile and healthy.  
3.5 Atg16L1E230 mice are deficient in LC3 associated phagocytosis  
The data above show that the phenotype of the Atg16L1E230 mouse was 
virtually indistinguishable from wild type littermate controls.   This 
showed that the WD domain of Atg16L1 was not required for 
maintaining tissue homeostasis in the major internal organs of the 
mouse.  All that was needed was an N-terminal Atg5-binding and CC 
98  
  
domain capable of binding WIPI2b. Recent studies have revealed a 
pathway related to autophagy called LC3 associated phagocytosis (LAP) 
which results in the translocation of LC3 from the cytosol to the limiting 
membrane of phagosomes containing pathogens.  To evaluate the role 
played by the WD domain of Atg16L1 in LAP macrophages isolated from 
Atg16L1E230 mice were starved with HBSS to induce autophagy or 
treated with polystyrene beads and monensin to trigger LC3-associated 
phagocytosis (LAP) (Figure 3.5). In this experiment monensin causes 
osmotic stress in the phagosome which provides a signal for LC3 
translocation (Florey et al, 2015).  Untreated cells did not show puncta. 
However, under HBSSstarved conditions, autophagosome formation was 
observed in wild type as well as Atg16L1E230 macrophages. As expected, 
Atg16L1E226 macrophages were unable to produce LC3 puncta due to 
compromised autophagy. When BMDM were also incubated with 
polystyrene beads and monensin, LC3 was recruited to the beads in wild 
type macrophages but not macrophages cultured from the Atg16L1E230 














Figure 3.4 Comparison between wild type, Atg16L1E226 and Atg16L1E230 
mice. i), ii) and iii) represent body size, body weight and liver weight, 
respectively. The p values < 0.05 were considered statistically significant 








Figure 3.5 Role played by the Atg5 binding and CCD of Atg16L1 in 
autophagy and LAP. BMDMs were cultured in growth medium (fed), 
treated with HBSS (starved) to induce autophagy, or with polystyrene 
beads and monensin to induce LAP. Cells were then probed for LC3. The 
white boxes show areas of the cell containing polystyrene beads. The 
zoomed-in images on the righthand side show that LC3 recruitment was 
observed in wild type but not macrophages cultured from Atg16L1E226 or 
















Chapter 4 Mechanism of suppression of IL-1beta 











4.1 Introduction and aims  
Interleukin-1beta (IL-1beta) is a potent pro-inflammatory cytokine that is 
essential for host-defence responses to infection and injury. It is a 
member of the IL-1 family and is one of the most vastly studied cytokine 
molecules. IL-1beta is secreted predominantly by cells of the immune 
system, such as macrophages and dendritic cells, and is produced as an 
inactive precursor, termed proIL-1beta, in response to recognition of 
lipopolysaccharide (LPS), a pathogen associated molecular patterns 
(PAMPs) carried by Gram negative bacteria and recognised by TLR4 
(Lopez-Castejon&Brough, 2011; Mosser&Edwards, 2008; Harris et al, 
2017). IL-1beta is essential for the adequate immune response to 
pathogen stimuli and is associated with exacerbated damage during 
chronic inflammation and acute tissue injury (Lopez-Castejon & Brough, 
2011).   
Recent studies indicate that the WD domain of Atg16L1 may supress 
pro-inflammatory cytokine production. One study suggests that the 
T300A mutation associated with Crohn’s disease, which is located in the 
linker region of the protein, generates a caspase-3 cleavage site that 
would result in removal of the WD domain following activation of 
caspase-3 during inflammation (Murthy et al, 2014). Another study 
demonstrates that LAP defects resulting from knock-out of rubicon in 
myeloid cells leads to an acute elevation of pro-inflammatory cytokine 
levels (Martinez et al, 2016).  
The aim of the current study is to evaluate the role of the Atg16L1 WD 
domain played in autophagy and LAP, and to investigate whether the 
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CCD is enough to suppress inflammation and cytokine production in 
response to LPS.  
4.2 LPS-induced autophagy  
As described in the previous chapter above, the Atg16L1E230 mouse lacks 
the linker and WD domains of Atg16L1 but retains the Atg16L1E230 
residue required for autophagy.  Interestingly, macrophages isolated 
from the Atg16L1E230 mouse were autophagy positive but were found to 
be deficient in LAP when challenged with polystyrene beads and 
monensin. The Atg16L1E226 mouse model carries a stop codon after the 
glutamate residue 226, which prevents the expression of the second 
glutamate at position 230 and is therefore deficient in both autophagy 
and LAP.   
LPS is reported to activate autophagy via TLR4 signalling (Deretic, 2012). 
To verify the ability of LPS to activate autophagy and recruit LC3 to 
autophagosome, BMDMs were treated with LPS (100 ng/ml) for 24h. 
The results were similar to those observed after cell starvation (Figure 
4.1i). WT and Atg16L1E230 BMDMs generated LC3 puncta whereas 
Atg16L1E226 macrophages did not show formation of puncta and were 
unable to activate autophagy in response to LPS. LC3-I/LC3-II conversion 
was investigated by Western blot of cell lysates taken from BMDMs 
before and after LPS treatment (Figure 4.1ii). Both WT and Atg16L1E230 
macrophages showed that the LC3-I levels decreased after LPS challenge 
suggesting degradation through autophagy.  It was not possible to see 
LC3-II, the reasons are not clear but may result from rapid degradation 
of LC3-II once it is attached to autophagosomes that then fuse with 
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lysosomes. This is supported by the higher levels of LC3-I in the 
Atg16L1E226 BMDMs that lack autophagy.  
Taken together, the results show that the CC domain of Atg16L1 is 
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Figure 4.1 LPS-induced autophagy. i) BMDMs were cultured in HBSS (starved) or 
treated with LPS (100 ng/ml) to induce autophagy. Cell were then probed for LC3 
(arrows show LC3-recruited puncta) (n=3); ii) BMDMs were cultured in growth 
medium (fed) or treated with LPS (100 ng/ml) to induce autophagy. Cell lysates 

























4.3 Deficient autophagy results in a significant IL-1beta increase in vitro 
and in vivo  
Saitoh and colleagues (2008) have shown that loss of the CC domain of 
Atg16L1 in BMDMs results in greatly increased secretion of IL-1beta.  In 
addition, as already mentioned, other studies implicate LAP in suppression 
of IL1-beta (Martinez et al, 2016). The availability of mice defective in 
autophagy and LAP (Atg16L1E226) and mice with selective loss of LAP 
(Atg16L1E230) allowed us to dissect the role of autophagy and LAP in IL-
1beta production and secretion further.   
IL-1beta secretion was investigated in vitro using BMDMs treated with LPS 
for 4h followed by a 30 min treatment with BzATP to activate the NLRP3 
inflammasome. Supernatants were then collected and analysed for IL-
1beta (Figure 4.2). Unstimulated cells showed low cytokine levels which 
were similar between the genotypes. LPS stimulation, however, resulted in 
a significant in IL-1beta secretion rising to 50 pg/ml for wild type controls.  
There was a dramatic increase to 250 pg/ml for the autophagy-deficient 
Atg16L1E226 macrophages. The Atg16L1E230 BMDMs showed elevation of IL-
1beta to 125 pg/ml but this was not significantly different from WT.    
To investigate if the same trend would be observed in vivo, mice were 
injected peritoneally with either PBS (control mice) or LPS (10 mg/kg). The 
procedure was conducted by Dr Devina Divekar. Blood samples were 
collected 90 min post-injection to measure serum IL-1beta production. 
Results were consistent with the in vitro study showing drastically 
increased cytokine serum levels after the LPS-challenge. Again, the 
autophagy-deficient Atg16L1E226 mice had the most dramatic IL-1beta 





              
Figure 4.2 IL-1beta production in Atg16L1 WT, Atg16L1E226 and 
Atg16L1E230 BMDMs. IL-1beta production from macrophages stimulated 
with LPS (1 μg/ml) for 4h followed by BzATP (150 μM) for 30 min. The p 
values < 0.05 were considered statistically significant (ns – not 
significant; ** < 0.01; *** < 0.001; **** < 0.0001). (n=3).  
  
  








Figure 4.3 IL-1beta production in Atg16L1 WT, Atg16L1E226 and 
Atg16L1E230 mice. IL-1beta in blood serum 90 min post-injection with LPS 
(10 mg/kg). The p values < 0.05 were considered statistically significant 











Harris and colleagues (2011) have shown that IL-1beta secretion in 
autophagy compromised dendritic cells is TLR4-dependent. In the study, 
3methyladenine (3MA) was used to inhibit autophagy and to determine 
which  
TLR ligands would increase IL1-beta secretion when autophagy was 
supressed.  They tested several TLR ligands and showed that only the 
TRL4 ligand, LPS, could increase IL-1beta secretion. Similarly, we 
cultured and treated BMDMs with CpG to activate TLR9; flagellin to 
activate TLR5; and MDP to activate NOD2. Figure 4.4 shows that IL-1beta 
secretion was LPS-inducible. The observed IL-1beta levels were 
considerably lower than what was observed in the previous experiment 
where macrophages were treated with LPS only. The reason might be 
the number of cells used in this experiment - due to insufficient 
material, only 20 000 cells/well were cultured and treated with TLR 
ligands. 
4.4 Levels of proIL-1beta protein are increased in macrophages 
cultured from the autophagy-deficient Atg16L1E226 mouse   
IL-1beta is produced as a 31 kDa precursor, termed proIL-1beta, which is 
cleaved upon stimulation, to form the 17 kDa active IL-1beta. Unlike IL-
1beta, proIL-1beta accumulates in the cytosol and can be detected after 
cell lysis.   
The finding that IL-1beta secretion was dramatically increased in the 
autophagy-deficient Atg16L1E226 mouse led us to ask whether its 
precursor, proIL-1beta, was also abundant. BMDMs were cultured and 
stimulated with LPS (100 ng/ml) for 24h. Supernatants were removed, 
cells were lysed and analysed for proIL-1beta by ELISA (Figure 4.5). 
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Untreated cells showed basal levels of proIL-1beta (20 pg/ml) which 
increased to 250 pg/ml when macrophages were stimulated with LPS. 
Basal levels of pro-IL1beta in Atg16L1E226 BMDMs were similar to control 
(30 pg/ml) but increased dramatically to 750 pg/ml in response to LPS.   
In contrast, the response of Atg16L1E230 BMDMs to LPS was similar to 
controls. The findings that both IL- and proIL-1beta showed a significant 
elevation in the Atg16L1E226 but not Atg16L1E230 BMDMs led us to ask 
whether the observed differences were due to increased gene 
expression. Macrophages were cultured and stimulated with LPS (100 
ng/ml) for 24h to induce IL-1beta transcription (Figure 4.6). Untreated 
BMDMs showed very low levels of IL-1beta. However, a dramatic 
increase in gene expression was observed after LPS treatment. 
Interestingly, no difference in IL-1beta transcription levels was observed 
















Figure 4.4 Role of TLR receptors in IL-1beta secretion from Atg16L1 WT, 
Atg16L1E226 and Atg16L1E230 BMDMs. Macrophages were cultured in 
growth medium (fed) or treated with LPS (1 μg/ml) for 4h and BzATP 
(150 μM) for 30 min, TLR4 ligand; CpG (10 μg/ml), TLR9 ligand; flagellin 
(10 μg/ml), TLR5 ligand; MDP (10 μg/ml), NOD2 ligand. The p values < 
0.05 were considered statistically significant (* < 0.05; **** < 0.0001). 
(n=3).  
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Figure 4.5 ProIL-1beta production in Atg16L1 WT, Atg16L1E226 and 
Atg16L1E230 BMDMs. Cells were cultured in growth medium (fed) or 
treated with LPS (100 ng/ml) for 24h. Cell lysates were then analysed 
with ELISA. The p values < 0.05 were considered statistically significant 











4.4.i ProIL-1beta is a substrate for autophagy  
The observation that both proIL- and IL-1beta were dramatically 
elevated in the autophagy compromised Atg16L1E226 mouse model, 
together with the finding that there was no difference in the IL-1beta 
mRNA levels between the genotypes, suggested that proIL-1beta maybe 
a substrate for autophagy. TLR4 stimulation activates NF-kB, a 
transcription factor that regulates various cellular processes, such as 
immune and inflammatory responses, cell growth, apoptosis, and 
developmental processes. Activated NF-kB induces the transcription of 
IL-1beta which is translated into the inactive pro- form. ProIL1beta is 
then cleaved by caspases to form the active IL-1beta which is secreted 
outside the cell (Qiao et al, 2012; Baeuerle&Henkel, 1994). Autophagy, 
however, as an anti-inflammatory process, and may target proIL-1beta 
for degradation (Figure 4.7). This would explain why the BMDMs from 
the autophagy compromised Atg16L1E226 mouse generated high levels of 
proIL- and IL-1beta.  
To provide evidence that autophagy targets proIL-1beta for degradation, 
proIL-1beta was tagged at the N-terminus with eGFP and expressed in 
cells to see if it co-locolizes with autophagosome marker LC3. After a 
24h transfection, cells were starved with HBSS for 3h to induce 
autophagy and the formation of autophagosomes was analysed by 
fluorescence microscopy using antibodies to LC3.  Co-localisation 





      
Figure 4.6 IL-1beta mRNA levels in Atg16L1 WT, ATg16L1E226 and 
Atg16L1E230 BMDMs. Macrophages were cultured in growth medium 
(fed) or treated with LPS (100 ng/ml) for 24h to induce IL-1beta gene 
expression. IL-beta mRNA levels were calculated using the ‘’relative 
copies’’ method where the expression of the gene of interested was 
measured in relation to the expression of the 18S gene. The p values < 
0.05 were considered statistically significant (ns – not significant; *** < 








Figure 4.7 Schematic representation of the possible role played by 
autophagy in IL-1beta production and secretion. i) IL-1beta mRNA is 
translated into the inactive proIL-1beta precursor which gets cleaved to 
form the active IL-1beta which is then secreted outside the cell (ii). 
Autophagy is an anti-inflammatory process which might target proIL-
1beta for degradation (iii), thus explaining the high pro- and IL-1beta 




In conclusion, our data suggest that levels of proIL-1beta and IL-1beta 
are raised in BMDMs from the Atg16L1E226 mouse because proIL-1beta is 
not removed by autophagy.  In this model LPS-induced TLR4 signalling 
activates NF-kB and induces expression of IL-1beta mRNA.  The mRNA is 
translated in the cytoplasm to generate proIL-1beta which is removed by 
autophagy.  This pathway may have evolved to supress inflammation.  
The analysis further indicates that the Atg5 binding and CC domains of 
Atg16L1 are sufficient to suppress proIL-1beta levels, and that control of 
IL-1beta appears to be independent of the linker and WD domains of 
Atg16L1. Experiments in Figure 3.6 show that these domains are 
required for LAP.  We can conclude therefore that LAP is not involved in 
suppression of IL-1beta production.   
   







Figure 4.8 ProIL-1beta and LC3 co-localization. 293HEKA cells were 
transfected with proIL-1beta_pcDNA3.1+N-eGFP for 24h and starved 
with HBSS for 3h to induce autophagy. ProIL-1beta appears as green 
puncta. The cells were stained for LC3 which is seen as red puncta. The 
arrows indicate the location of proIL-1beta (first panel of images), LC3 


















Chapter 5  
Mechanism of suppression of inflammasome 














5.1 Introduction and aims  
It has been reported that the major pathway for conversion of proIL-
1beta to IL-1beta is the activation of caspase-1 by the inflammasome 
(Gurung&Kanneganti, 2015). Inflammasomes are multimeric protein 
complexes that assemble in the cytosol upon infection or after sensing 
PAMPs or DAMPs and can therefore be considered as innate immune 
system receptors (Guo et al, 2015). They consist of NLR family members 
and the adaptor apoptosis-associated speck-like (ASC) protein. Three 
inflammasomes have been characterized – NLRP1, NLRP3, and NLRP4 – 
with the main differences being the stimuli and the mechanisms of 
action (Franchi et al, 2009). Despite the differences, however, canonical 
inflammasomes serve as a platform for caspase-1 recruitment and 
activation (Guo et al, 2015).  
Caspase-1 is a member of the intracellular cysteine protease family 
which induces inflammation through the activation of proinflammatory 
cytokines, such as IL-1beta and IL-18 (Franchi et al, 2009). Upon 
stimulation, the inactive zymogen pro-caspase-1 binds to ASC which 
results to its oligomerization and subsequent autoproteolytic cleavage 
into the enzymatically active heterodimer consisting of two 10 and 20 
kDa subunits. Active caspase-1 cleaves the precursor proIL-1beta and 
generates the biologically active IL1beta (Guo et al, 2015).   
It has been demonstrated that IL-1beta is also regulated by caspase-8. 
Although the mechanism of its activity is not fully understood, it is 
believed that caspase-8 regulates IL-1beta through pathways that are 
dependent upon the inflammasome. Studies have proposed that 
caspase-8 regulates NF-kB to modulate inflammation 
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(Gurung&Kanneganti, 2015). It has been shown that caspase-8 directly 
cleaves proIL-1beta at the same site as caspase-1 (Vince et al, 2012; 
Man&Kanneganti, 2016). It has also been suggested that caspase-8 is a 
part of the NLRP3 inflammasome and is involved in caspase-1 processing 
and cleavage (Gurung&Kanneganti, 2015).  
A20, a suppressor of the NLRP3 inflammasome, has been shown to 
inhibit NFkB and restrict ubiquitination of proIL-1beta. It has been 
demonstrated that A20 co-precipitates with caspase-1 and caspase-8 
and prevents spontaneous secretion of IL-1beta, thus preventing 
inflammatory diseases (Duong et al, 2015).  
The aim of the current study is to investigate the role of autophagy and 
LAP in the activation of the inflammasome proteins with regards to IL-
1beta induction and secretion.    
5.2 Compromised autophagy results in increased caspase-1 and 
caspase-8 activity  
Since both caspase-1 and caspase-8 cleave the precursor proIL-1beta to 
generate the active form of IL-1beta, we sought to investigate whether 
the increased IL-1beta levels in autophagy-compromised macrophages 
were due to increased caspase activity. BMDMs were incubated in 
growth medium or treated with LPS (1 μg/ml) for 4h followed by a 30 
min incubation with BzATP (150 μM) to activate the NLRP3 
inflammasome. Cells and supernatants were pooled to measure caspase 
activity in each genotype.  The macrophages from the Atg16L1E226 mice 
showed high basal levels of caspase-1 and caspase8 compared to 
controls (Figure 5.1i and 5.1ii). The macrophages from the Atg16L1E230 
mice showed raised basal caspase activity intermediate between 
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Atg16L1E226 and control.  In each case, incubation with LPS and BzATP 
increased caspase-1 and caspase-8 activity, but the greatest increase 
was seen in BMDMs from Atg16L1E226 mice.  
The big increase in caspase activity in the Atg16L1E226 mouse model 
raised the question whether caspase-1 and capsase-8 are substrates for 
autophagy upon LPS stimulation. To investigate this hypothesis, WT 
BMDMs, i.e. macrophages with intact autophagy, were stimulated with 
LPS (1 μg/ml) for 4h followed by a 30 min treatment with BzATP (150 
μM). Cells were then immunostained for LC3 (green) and caspase-1 (red) 
(Figure 5.1iii). LC3 puncta were produced in the stimulated cells and 
caspase-1 was located to small punctate structures in the cytoplasm.  
However, no co-localization was observed between the two proteins, 
indicating that even though caspases mediate proIL-1beta cleavage and 
IL-1beta production, it was not possible to provide evidence for 
degradation of caspase-1 by autophagy. With the time available, it was 
not possible to investigate whether caspase-8 co-localizes with LC3 and 
is therefore a substrate for autophagy.  
Taken together, our findings demonstrate that lack of autophagy results 
in a significant increase in caspase-1 and caspase-8 activity which is 
concordant with previous studies showing that deficiency in autophagy 
proteins, such as LC3 and beclin 1, activates caspase-1 (Nakahira et al, 
2011). In the study, Map1lc3-/- and Becn1+/- peritoneal macrophages 
were used to investigate the role of autophagy in inflammasome 
activation. The results demonstrated that the mechanism by which 
autophagic proteins regulate caspase-1 activation was due to their 
contribution to mitochondrial quality control. Autophagy-compromised 
macrophages presented with abnormal mitochondria which produced 
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more ROS. Also, the study demonstrated a relationship between the 
generated mitochondrial ROS and the activity of caspase-1, showing that 
mitochondrial complex I inhibitor rotenone enhanced caspase-1 
activation and IL-1beta secretion.  The mechanism of caspase-8 activity 
is still unclear. As already discussed, caspase-8 has been revealed to be 
involved in caspase-1 activation as well as IL-1beta processing. It has 
also been suggested that both caspases work synergistically. 
Interestingly, Kovacs and colleagues (2011) have shown that autophagy 
compromised T-cells, deficient for beclin-1, accumulate caspase-8 
aggregates. That might explain the increased caspase-8 activity in the 
autophagy negative Atg16L1E226 cells. The exact mechanisms, however, 
are yet to be elucidated No co-localization was observed between LC3 
and caspase-1, indicating that while proIL-1beta may be sequestered 














                                       
Figure 5.1 Caspase activity in Atg16L1 WT, ATG16L1E226 and Atg16L1E230 
macrophages. i) and ii) BMDMs were cultured in growth medium or 
treated with LPS (1 μg/ml) for 4h, followed by BzATP (150 μM) for 30 
min. Caspase activity is presented in relative light units (RLU). The p 
values < 0.05 were considered statistically significant (* < 0.05; ** < 
0.01). (n=3); iii) WT BMDMs were stimulated with LPS for 4h (1 μg/ml), 
followed by treatment with BzATP (150 μM) for 30 min. Cells were then 
probed for LC3 and caspase-1. The arrows indicate the location of LC3 
(green puncta) and caspase-1 (red puncta). The white box is a zoomed-in 
image of an area containing both LC3 and caspase-1. (n=3). 
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5.3 Deficient autophagy does not affect NLRP3 production and 
expression  
NLRP3 is the most extensively investigated of the inflammasomes 
(Sutterwala et al, 2014). Upon stimulation, the main inflammasome 
protein, NLRP3 oligomerizes and interacts with the adaptor protein ASC 
which results in caspase-1 activation (Qiao et al, 2012). It has also been 
demonstrated that caspase-8 is also involved in NLRP3 induction (Chi et 
al, 2014). Therefore, we sought to assess NLRP3 expression in both 
Atg16L1E226 and Atg16L1E230 BMDMs. Macrophages were treated with 
LPS (1 μg/ml) for 4h before analysis by qRT-PCR (Figure 5.2i).  
Gene expression was upregulated by LPS but no difference in 
upregulation was observed between genotypes. The analysis was 
repeated by Western blot (Figure 5.2ii). Consistent with the qRT-PCR 
results, levels of NLRP3 increased in response to LPS but no increase was 
observed in the Atg16L1E226 macrophages which suggests that NLRP3 is 
unlikely to be a substrate for autophagy. If that was the case, the 









                    
                
 
Figure 5.2 NLRP3 gene and protein expression in Atg16L1 WT, Atg16L1E226 and 
Atg16L1E230 BMDMs. i) Cells were cultured in growth medium or treated with LPS 
(1 μg/ml) for 4h before RNA extraction and analysis by qPCR. The p values < 0.05 
were considered statistically significant (*** < 0.001; **** < 0.0001) (n=3); ii) 
Cells were cultured in growth medium or treated with LPS (1 μg/ml) for 4h. The 
cell lysates were then blotted for NLRP3. (n=3). 
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5.4 Autophagy compromised BMDMs show an increase in A20 
expression  
It has been reported that the ubiquitin-modifying enzyme A20 associates 
with caspase-1 and proIL-1beta and is recruited to the NLRP3 
inflammasome. It has also been suggested that it restricts proIL-1beta 
ubiquitination through RIPK and prevents the spontaneous secretion of 
the biologically active IL-1beta (Duong et al, 2015). This made it possible 
that increased levels of IL-1b would be produced if A20 were degraded 
by autophagy. Therefore, the levels of A20 in both Atg16L1E226 and 
Atg16L1E230 were investigated. BMDMs were treated with LPS (1 μg/ml) 
for 4h before qRT-PCR and Western blotting (Figure 5.3). As seen for 
NLRP3 expression, mRNA levels for A20 were increased following 
incubation with LPS but the increases did not show any changes 
between the genotypes (Figure 5.3i). However, protein levels were 
increased in the autophagy-deficient Atg16L1E226 BMDMs (Figure 5.3ii). 
This suggests that A20 is a substrate for autophagy,and is consistent 
with previous studies that have demonstrated that A20 co-localizes with 
p62, an autophagic adaptor protein, in tissue macrophages and is 
sequestered for degradation in the autophagosome (Kanayama et al, 
2015).  The observations do not easily explain increased levels of IL-
1beta, based on the model provided from Duong and colleagues (2015), 
where increased A20 would be expected to decrease processing of IL-
1beta by caspase-1. There is, however, an important difference between 
activation of proIL1beta and levels of proIL-1beta protein.  The results in 
figure 4.2 show increased levels of IL-1beta in BMDMs from Atg16L1E226 
mice, suggesting that pro-IL1beta is degraded by autophagy.  The 
observation that A20 binds proIL-1beta, and is also a substrate for 
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autophagy, raises the possibility that A20 may target proIL-1beta for 
autophagy. This could be tested by silencing A20 which should raise IL-
1beta levels.    
Taken together, our data demonstrate that the increase of IL-1beta 
levels in the Atg16L1E226 mouse model is due to increased caspase 
activity although caspase-1 does not seem to be a substrate for 
autophagy. NLRP3 did not show an expression elevation in the absence 
of autophagy. The increased levels of A20, however, suggest that it 
might be a target for autophagosomal degradation and a possible 












Figure 5.3 A20 gene and protein expression in Atg16L1 WT, Atg16L1E226 
and Atg16L1E230 BMDMs. (i) Cells were cultured in growth medium or 
treated with LPS (1 μg/ml) for 4h before RNA extraction and analysis by 
qPCR. The p values < 0.05 were considered statistically significant (**** < 
0.0001). (n=3); ii) Cells were cultured in growth medium or treated with 
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Mechanism of regulation of macrophage 












6.1 Introduction and aims  
Macrophages are an essential component of the innate immune 
response and represent the first line of defence against pathogens. 
Moreover, they are involved in homeostasis, tissue remodelling, wound 
healing, and can affect tissue metabolism. On one hand, macrophages 
have extrinsic metabolic functions by releasing cytokines; on the other 
hand, their intrinsic metabolic functions shape their activation state. 
Upon environmental stimulation, they acquire distinct phenotypes 
(Biswas& Mantovani, 2012). In response to various signals, macrophages 
may undergo classical M1 or alternative M2 activation (polarization). 
The M1 polarized macrophages secrete high amounts of pro-
inflammatory cytokines and are characterized with a high production of 
reactive nitrogen and oxygen intermediates. They are implicated in 
initiating and sustaining of inflammation whereas the M2 macrophages 
promote tissue repair and have immunoregulatory functions 
(Sica&Mantovani, 2012).   
It has long been known that macrophage functions and metabolism are 
tightly connected (Biswas& Mantovani, 2012). An increasing number of 
studies have emphasized the significance of investigating the link 
between the metabolic state and the phenotype of immune cells 
(Galvan-Pena&O’Neill, 2014). Moreover, defining the mechanisms of 
macrophage metabolic activity and regulation is crucial to pathology 
(Biswas&Mantovani, 2012).  
Loss of autophagy in macrophages and other myeloid cells in vivo is 
associated with increased inflammation.  This has been referred to as a 
‘bystander or extrinsic autophagy’’ by Lu and colleagues (2016) and well 
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as Park and colleagues (2016),and differs from intrinsic autophagy 
where autophagy protects against infection by degrading pathogens 
inside cells. In this model, loss of autophagy from macrophages and 
other myeloid cells increases proinflammatory responses and raises the 
inflammatory threshold in vivo.  This can protect against infection 
because invading microorganisms encounter a pre-activated immune 
system, or lead to inflammatory disease if inflammation is not 
controlled, e.g. Crohn’s disease.  
The Atg16L1 T300A Crohn’s disease model predicts that the T300A risk 
allele generates caspase-3 cleavage site that is cleaved by caspase-3 
activated during inflammation.  It is thought that this inactivates 
Atg16L1 leading to loss of autophagy and increased inflammation 
(Murthy et al, 2014).  Caspase-3 cleavage removes the WD domain of 
Atg16L1 and leaves the Atg5 binding and CC domains of Atg16L1 intact.  
The work in the previous chapters studying BMDMs from Atg16L1E230 
mice has shown, however, that these domains of  
Atg16L1 are sufficient to maintain autophagy and supress IL-1beta 
secretion.  This chapter analyses the effects of loss of the WD domain on 
macrophage polarization, oxygen consumption and glycolytic activity.  
6.2 Macrophage polarization  
6.2.i Compromised autophagy skews macrophage polarization to an 
M1 phenotype  
It has been shown that in response to various stimuli, immune cells 
rapidly adapt their metabolic profiles to defend the host and meet its 
needs. Upon intracellular or bacterial infection, or after IFN-gamma 
stimulation, macrophages obtain the M1 phenotype which is 
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characterised by the generation of various metabolites or cytokines, 
called M1 markers, involved in the killing of the pathogen (Galvan-
Pena&O’Neill, 2014). Here we investigated the expression of two M1 
markers: IL-6, an important mediator of the acute phase response which 
also stimulates the production of neutrophils and supports the growth 
of B cells (Hunter&Jones, 2015); and Ptgs2 (COX2), involved in the 
production of prostaglandins which play an essential role in 
inflammation (Morita, 2002).   
BMDMs were incubated in growth medium or treated with LPS (100 
ng/ml) and IFN-gamma (100 ng/ml) for 24h before qRT-PCR was 
performed (Figure 6.1). Untreated BMDMs showed very low basal levels 
of IL-6 and Ptgs2. A dramatic increase in gene expression was observed 
after LPS and IFN-gamma stimulation but the greatest elevation was 
seen in BMDMs from Atg16L1E226 mice. Increases in IL-6 and Ptgs2 in the 
Atg16L1E230 cells were similar to controls.  
6.2.ii Compromised autophagy inhibits M2 macrophage polarization   
The M2 macrophages are associated with tissue repair, 
immunoregulation and chronic inflammation resolution 
(Sica&Mantovani, 2012). Exposure to fungi or parasites, or after 
stimulation with IL-4 or IL-13, macrophages obtain the M2 phenotype 
which is characterised by the production of metabolites, receptors and 
chemokines, called M2 markers, involved in pathogen clearance, tissue 
repair, or inflammation resolution (Roszer, 2015). The expression of two 
M2 markers: Arg1, a tissue healing regulator which also reduces the T-
cell response; and Chil3, involved in inflammatory response which also 
displays a chemotactic activity for T lymphocytes (Roszer, 2015) were 
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analysed after incubation of BMDMs with IL-4 (10 ng/ml) and IL-13 (20 
ng/ml) for 24h before qRT-PCR (Figure 6.2).  Untreated cells showed low 
basal levels of the M2 polarization markers. After stimulation with IL-4 
and IL-13, however, both Arg1 and Chil3 showed a significant expression 
decrease in the BMDMs from the autophagy-deficient Atg16L1E226 
mouse. Both Atg16L1E230 and WT macrophages showed a 3-fold increase 
in the expression of Chil3 in response to treatment with IL-4 and IL-13. 
The same 3-fold pattern was observed in the Arg1 expression as well, 
however, the Chil3 levels in the Atg16L1E230 macrophages showed a 
decrease compared to the WT which might be due to the lower starting 
expression in the latter. Since the Atg16L1E230 macrophages are LAP-
compromised, one possible speculation might be that LAP interacts with 
the Chil3 production pathway. Taken together, the results demonstrate 
that loss of autophagy leads to increased susceptibility to pro-
inflammatory M1 phenotype, but this susceptibility is not caused by a 











             
                 
Figure 6.1 Gene expression levels of IL-6 and Ptgs2 in Atg16L1 WT, 
Atg16L1E226 and Atg16L1E230 BMDMs. Cells were treated with LPS (100 ng/ml) 
and INF-gamma (100 ng/ml) for 24h. The p values < 0.05 were considered 




Figure 6.2 Gene expression levels of Arg1 and Chil3 in Atg16L1 WT, 
Atg16L1E226 and Atg16L1E230 BMDMs. Cells were treated with IL-4 (10 
ng/ml) and IL-13 (20 ng/ml) for 24h. The p values < 0.05 were 
considered statistically significant (* < 0.05; ** < 0.01). (n=3) 
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6.3 Metabolic flux analysis of BMDM to determine any phenotypic  
differences in glycolysis and OXPHOS  
The respiratory profile of the different genotypes was investigated using 
the stress tests to examine any differences in glycolytic and 
mitochondrial function thereby determining the two major energy-
producing pathways in a cell. Differences in glycolytic function may 
identify alterations in how glucose is utilised between the genotypes by 
examining the maximum glycolysis capacity. Where differences in the 
mitochondrial function allow the determination of cellular metabolic 
function, for example it may highlight differences in mitochondrial leak 
or damage between the genotypes that would directly affect the 
amount of ATP generated per glucose molecule.  
6.3.i Glycolysis stress test  
Figure 6.3i-ii shows glycolytic metabolism for BMDMs derived from wild 
type, Atg16L1E230 (top) and Atg16L1E226 (bottom) mice respectively, 
analysis showed an increase in ECAR in response to a first injection of a 
saturating concentration of glucose (10mM), this enhanced ECAR 
indicated glycolysis under basal conditions (histogram figure 6.4i, iv). 
Thereafter, oligomycin was injected to block OXPHOS and shifted the 




Figure 6.3: Glycolysis and Mitochondrial stress test average data for 
wild type (WT) versus Atg16L1E230 and Atg16L1E226 BMDMs. Pooled data 
showing extracellular acidification rate versus time (glycolysis stress 
test), (i) WT versus Atg16L1E230, (ii) WT versus Atg16L1E226 mice, and 
oxygen consumption rates versus time (mitochondrial stress test), (iii) 
WT versus Atg16L1E230 and (iv) WT versus Atg16L1E226 mice. Numbers of 
separate mice used are indicated below each key. No significant 
differences were found between the mutant versus wild type 




 capacity (histogram figure 6.4ii, v) though no clear response to 
oligomycin was observed. The final injection of a saturating 
concentration of 2-DG competitively inhibited glucose hexokinase, the 
first enzyme in the glycolytic pathway (see Materials and Methods, 
figure 2.5) and confirmed the ECAR values measured were due to 
glycolysis. Glycolytic reserve (histogram Figure 6.4iii, vi) was calculated 
as the difference between glycolysis (i) and glycolytic capacity (ii) and 
argued all cells were functioning at near maximal glycolysis to generate 
ATP. No significant differences (Student’s t-test) were found between 
any flux analysis undertaken.  
6.3.ii Mitochondrial stress test   
Figure 6.3iii-iv shows the oxygen consumption rate (OCR) for 
macrophage cells derived from wild type, Atg16L1E230 and Atg16L1E226 
mice. Basal respiration was determined immediately prior to the 
injection of oligomycin (histogram figure 6.5i, iv) and excluded non-
mitochondrial respiration. Thereafter, a small decrease in oxygen 
consumption was shown in response to oligomycin injection, an 
inhibitor of complex V (see Materials and Methods, figure 2.7), and 
directly indicated the proportion of basal respiration oxygen 
consumption that was related to ATP production (histogram figure 6.5iii-
iv). A subsequent injection of the mitochondrial un-coupler FCCP that 
collapses the proton gradient and mimics a metabolic challenge resulted 
in maximum cellular oxygen consumption by complex IV. The final 
injection of rotenone, a complex I inhibitor, and antimycin-A, a complex 
III inhibitor, ceased all OXPHOS and identified any OCR that was 
unrelated to OXPHOS. This measure of nonOXPHOS OCR subtracted 
from OCR utilised for ATP production allowed the proton leak 
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(histogram figure 6.5ii, v) to be calculated and was an indication of 
mitochondrial damage. Overall no significant differences (Students t-
test) were found between comparisons of these data between WT or 
mutant BMDMs irrespective of genotype. 
  
 
 Figure 6.4: Histograms showing average data for respiratory parameters from a glycolysis stress test. Bar chart 
graphs from Atg16L1E230 (n=4, i-iii) and Atg16L1E226 (n=5, iv-vi) versus wild type mice (n=6&4, respectively) showing 
bone marrow-derived macrophage glycolytic metabolic function. Where glycolysis (i,iv), glycolytic capacity (ii, v) 
and glycolytic reserve (iii, vi) showed no significant differences between the mutant and wild type phenotypes 
(Student’s t-test).  
 
  
Figure 6.5: Histograms showing average data for respiratory parameters from a mitochondrial stress test. Bar 
chart graphs from Atg16L1E230 (n=4, i-iii) and Atg16L1E226 (n=3, iv-vi) versus wild type mice (n=5&3, respectively) 
showing bone marrow-derived macrophage OXPHOS metabolic function. Where basal respiration (i, iv), proton leak 
(ii, v) and ATP production (iii, vi) showed no significant differences between the mutant and wild type phenotypes 

























7.1 Atg16L1, LAP and inflammation  
As described above, autophagy plays important roles in tissue 
homeostasis and development and provides a short-term supply of 
amino acids to sustain protein and energy production during starvation.  
Autophagy is also important in the immune system where it can 
suppress excessive inflammation during microbial infections and 
degrade pathogens in lysosomes to increase presentation of pathogen 
components to the immune system.  The Atg16L1 protein is essential for 
autophagy and is composed of two main domains: the combined atg5-
binding:CCD which is at the N-terminus of the protein, and a C-terminal 
WD repeat domain.   This study has used mouse models to analyse the 
role played by these domains in suppressing inflammatory responses by 
macrophages.    
The atg5-binding:CCD of Atg16L1 provides a binding site for PtdIns(3)P 
effector protein WIPI2b which ensures that the Atg12:5:16L1 complex 
can deliver lipidated LC3 (LC3-II) to the autophagosome membrane. 
Both mouse models lack the WD domainbut vary in their ability to bind 
WIPI2b.  The CCD of the Atg16L1E226 mouse lacks the E230 residue 
required for binding to WIPI2b, and cells isolated from the mouse are 
negative for autophagy and autophagosome formation.  The CCD of the 
Atg16L1E230 mouse retains the E230 residue necessary for WIPI2b 
binding and cells isolated from the mouse are positive for autophagy 
and autophagosome formation.   Autophagy does not therefore require 
the WD domain of Atg16L1 and only requires an atg5-binding:CCD able 
to bind WIPI2b.  Related experiments have been carried out by Saitoh et 
al (2008).  In their experiment the Atg16L1 gene was modified so that 
the mouse expressed the WD domain but not the atg5-binding:CCD.  
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These mice were autophagy negative and died of post-natal starvation.  
The experiments showed that the CCD is required for autophagy but did 
not exclude the possibility that both the atg5-binding:CCD and the WD 
of Atg16L1 are required for autophagy in mice.  The experiments in this 
thesis are the first to study mice expressing the atg5-binding:CCD but 
lacking the WD domain.  The Atg16L1E230 mouse was autophagy positive 
and survived post-natal starvation, indicating that the mouse could 
maintain autophagy in vivo without the WD domain. This surprising 
result suggests that the scaffold generated by the 8 WD domains of the 
800kD Atg5-12:16L1 hexamer, containing 56 beta propellers, are not 
involved in protein:protein interactions required for suppressing 
inflammation. Instead, evolution appears to have confined this 
important role to the N-terminal atg5-binding and CC domains 
conserved through to yeast.  Further studies using macrophages 
cultured from Atg16L1E230 mouse bone marrow showed that the mice 
were defective in LAP.  At the time of writing, this is the first evidence 
that the WD domain of Atg16L1 is required for LAP.  This will prompt 
further work to understand how the 56 beta propellers of the Atg5-
12:16L1 hexamer control the recruitment of LC3 to phagosomes 
containing pathogens as they enter cells.  
The Atg16L1E226 and Atg16L1E230 mice provided a source of macrophages 
to study the roles played by autophagy and LAP in controlling IL-1beta 
secretion and M1/M2 polarisation.  Taken together, the results showed 
that autophagy, rather than LAP, was important for controlling IL-1beta 
secretion in response to LPS-mediated TL4 signalling. Caspase-1 and 
caspase-8 activity as well as levels of A20 were also raised in the 
absence of autophagy, but again were not affected by loss of LAP.  With 
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the time available, it was not possible to show that caspase-8 and A20 
were cargoes for autophagy and degraded in lysosomes. Caspase-1 did 
not show co-localization with LC3, suggesting that proIL-1beta is 
segregated from caspase-1. Autophagy, rather than LAP, was also 
involved in pushing macrophage polarisation towards an M2, anti-
inflammatory phenotype.    
The effects of autophagy and LAP were also studied in the context of the 
signalling proteins that act upstream of IL-1beta processing.  A20 is a 
signalling molecule that restricts inflammation by inhibiting NF-kB 
signalling. Polymorphisms and mutations in Tnfaip3, the gene encoding 
A20, have been linked to inflammatory, malignant and autoimmune 
diseases. Interestingly, our experiments showed a significant increase in 
A20 protein expression in the Atg16L1E226 macrophages compared to 
control and Atg16L1E230. This finding suggests that A20 might be a 
substrate for autophagy. Moreover, previous studies have 
demonstrated that A20 co-localizes with p62, an autophagy adaptor 
protein, in tissue macrophages and is sequestered for degradation in the 
autophagosome (Kanayama, 2015). The observations do not easily 
explain increased levels of IL-1beta, based on the results obtained by 
Duong et al (2015), where Tnfaip3-/- BMDMs showed an increase in IL-
1beta secretion compared to control wild type cells after LPS 
stimulation.  
Therefore, increased A20 would be expected to decrease processing of 
IL-1beta by caspase-1. There is, however, an important difference 
between activation of proIL-1beta and levels of proIL-1beta protein.  Our 
results show increased levels of IL-1beta in BMDMs from Atg16L1E226 
mice, suggesting that proIL-1beta is degraded by autophagy.  The 
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observation that A20 binds proIL-1beta, and is also a substrate for 
autophagy, raises the possibility that A20 may target IL-1beta for 
autophagy. This could be tested by silencing A20 which should raise IL-
1beta levels. Moreover, A20 has been reported to be capable of 
targeting signalling molecules, such as TRAF2, to the lysosomes for 
degradation (Li et al, 2009).  
7.2 Macrophage metabolism  
It has long been known that macrophage functions and metabolism are 
tightly connected (Biswas&Mantovani, 2012). An increasing number of 
studies have emphasized the significance of investigating the link 
between the metabolic state and the phenotype of immune cells 
(Galvan-Pena&O’Neill, 2014). Moreover, defining the mechanisms of 
macrophage metabolic activity and regulation is crucial to pathology 
(Biswas&Mantovani, 2012). Here we show that unlike the autophagy-
deficient Atg16L1E226 macrophages, the LAP-compromised Atg16L1E230 
cells do not skew macrophage polarization into the pro-inflammatory 
M1 phenotype. Moreover, the Atg16L1E230 cells were not able to inhibit 
the anti-inflammatory M2 phenotype.   
Autophagy is a process of general cellular housekeeping. It is predicted 
that where autophagy is absent, damaged proteins should start to 
accumulate. If this were to occur in the mitochondria, it might be 
expected that their ability to undergo OXPHOS might be compromised, 
similarly for the glycolytic pathway. We used the Mito stress test and 
glycolysis stress test to determine any differences in OXPHOS or 
glycolysis, respectively, between the different mouse genotypes. 
Analysis of OXPHOS showed no difference between the Atg16L1E226 and 
Atg16L1E230 macrophages versus wild type mice, nor were any 
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differences found for the glycolytic stress test. This argues the metabolic 
function of ATP generation using both OXPHOS or glycolysis is 
unaffected by autophagy or LAP, it further argues that if misfolded 
proteins or damaged organelles accumulate in Atg16L1E226 and 
Atg16L1E230 macrophages, they do not alter energy metabolism. It is also 
notable that the BMDMs predominantly use glycolysis at near maximal 
rates as no increase in ECAR was evident to oligomycin treatment that 
shuts down OXPHOS and should force the cells to use glycolysis only to 
make ATP.  Furthermore, the glycolytic reserve is low as there was no 
increase in ECAR after oligomycin treatment and argues the ability of the 
cell to fill an energetic demand in response to a stress may not be fully 
satisfied by glycolysis. However, there is appreciable spare OXPHOS 
capacity that could supply additional ATP when demand is required. 
These observations are consistent with previous studies showing no 
mitochondrial alternations in Atg16L1-/- resting B-cells when compared 
to wild type (Martinez-Martin et al, 2017).   
7.3 Atg16L1, Crohn’s disease and LAP   
The context of how the Atg12:5:16L1 complex is processed becomes 
important in relation to Crohn’s disease where a mutation at T300A of 
Atg16L1 yields a caspase-3 sensitive site that can generate truncated 
Atg16L1 which only contains an intact CCD, but lacks the WD repeats. 
Several studies, mostly characterising the T300A mutation associated 
with Crohn’s disease, suggest that the WD domain is important for 
controlling inflammation. One study suggests that the T300A mutation, 
located in the linker region of the protein, generates a caspase-3 
cleavage site making Atg16L1 susceptible to cleavage when caspase-3 is 
activated during inflammation.  Murthy et al (2014) show that this 
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results in diminished autophagy and increased cytokine production. 
Another study demonstrates that knock-out of rubicon in myeloid cells, 
a key protein in the LAP pathway, does not affect autophagy, but leads 
to an acute elevation of pro-inflammatory cytokine levels (Martinez et 
al, 2016). This thesis has demonstrated elevated proIL-1beta protein 
levels when autophagy is lost in the Atg16L1E226 macrophages but did 
not provide evidence for a significant increase for the Atg16L1E230 
macrophages.  These results are contrary to the conclusions of studies of 
the T300A mutation because they suggest that the atg5-binding:CCD of 
Atg16L1 is sufficient to suppress inflammation.  Loss of the WD domain 
following caspase-3 cleavage would not be expected to increase pro-
inflammatory cytokine production.   
In this sense, Atg16L1E230 mouse model is not the same as the T300A 
Crohn’s model contrary to the expectations. It is worth noting that the 
stop codon in the Atg16L1E230 mouse is located immediately after the 
CCD domain whereas in the T300A model, part of the linker region of 
Atg16L1 is preserved. Depending on the conformational status of the 
protein and in the absence of the WD domain, the linker in the T300A 
might be responsible for the pro-inflammatory response that is 
observed in this model. Another possibility that should be considered is 
based on the fact that in human T300A cells, inflammation activates 
caspase-3 which in turn cleaves Atg16L1 at T300A resulting in 
accumulation of free WD within the cell. This protein accumulation 
might be a signal which triggers an inflammatory response. In the case 
of Atg16L1E230, however, such accumulation is not possible due to the 
lack of the WD domain. To investigate the possible reasons for the 
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observed results, future work should be aimed at investigating the role 
of the linker region in the Atg16L1 protein. 
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                                                    Appendix  
Below is an abstract summarizing the work done between October 
2013 and May 2015 that had to be terminated upon the leaving of my 
supervisor Dr Nigel Belshaw.  
  
Abstract  
It has long been known that DNA methylation can influence gene 
expression and thus result in disease. Colorectal cancer is one example 
of a disorder which results from a progressive accumulation of genetic 
and epigenetic alterations. Polymorphisms in different genes have been 
associated with a higher risk or overall survival in cancer. Global DNA 
hypomethylation and gene-specific hypermethylation have both been 
linked to the process of tumour growth and progression. Autophagy, a 
lysosomal degradation pathway of cellular proteins and organelles, on 
the other hand, has a dual role in tumorigenesis. Genetic evidence has 
suggested that autophagy has tumour suppressive functions during the 
first initiation step. Various monoallelic deletions in genes involved in 
autophagy have been found in a high percentage of human cancers. 
However, there is also compelling evidence that autophagy promotes 
the survival of established tumours during progression and metastasis. It 
is believed that autophagy provides cancer cells with selective 
advantages to cope with stress conditions such as hypoxia, for example. 
However, little is known about the cancer-related genetic and epigenetic 
alterations of the genes involved in autophagy. To address this question, 
DNA methylation analysis was performed on TFEB, TLR9, NOD2, Atg5, 
Atg12, and Atg16L1 in tumour, adjacent normal and healthy control 
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samples. Based on the variations observed, gene expression analysis was 
also carried out in tumour vs adjacent normal samples. However, the 
importance of the differences in gene expression in regard to autophagy 
activity in cancer remains to be established. Additional statistical 
analyses were carried out to investigate the relationships between DNA 
methylation and age, gender and tumour location. Significant 
associations were identified suggesting that age, gender and tumour 
location can influence the pattern of DNA methylation. Further work is 
required to understand the functional consequences of these 
observations for autophagy activity.  
  
